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Abstract 
Fetal growth restriction (FGR) is defined by low birth weight and contributes to a variety of adult-
onset diseases with different severities between males and females. However, the effects of FGR 
on the pulmonary surfactant are not fully elucidated. In this thesis, first, we investigated the FGR 
effects on the lung function and the surfactant system at the early postnatal life. It was hypothesized 
that FGR contributes to alterations of lung mechanics and the surfactant system during the neonatal 
period. Second, we assessed the FGR effects on the surfactant system in response to sepsis in 
adulthood. It was hypothesized that FGR contributes to the alteration of the surfactant system in 
response to sepsis in adulthood. Overall, the data suggest that FGR induced by maternal protein 
restriction affects lung compliance at the early life and predispose the septic adults to the 
development of surfactant alterations in a sex-specific manner.  
 
 
 
 
 
 
 
 
Keywords:  
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Chapter 1-General Introduction and Literature Overview  
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 2 
1.1. Overview  
Over the last few decades, it has become evident that an adverse intrauterine environment 
during pregnancy leads to fetal growth restriction (FGR) and can have immediate and long-
term health impacts in both male and female offspring (Barker et al., 1991; Hoo et al., 
2004; Rueda-Clausen, Morton, & Davidge, 2009). FGR is defined as small for gestational 
age (Mamelle, Cochet, & Claris, 2001; Sohi et al., 2011). FGR contributes to the 
development of diseases such as diabetes and cardiovascular disorders, often with different 
outcomes in males and females (Carey et al., 2007; Ozaki et al., 2001; Ozanne et al., 1998; 
Petry, Ozanne, & Hales, 2001; Rozance et al., 2011). Comparatively, the impact of FGR 
on the lung development and function in the neonatal period and its contribution to the 
development of lung diseases later in life, has received far less attention. Several studies 
have provided preliminary indications that FGR does indeed have impacts on the 
pulmonary system (Mestan & Steinhorn, 2011; Real et al., 2010; Rozance et al., 2011; 
Sugahara et al., 1983; Visentin et al., 2014). These effects include alterations in lung 
mechanics and the pulmonary surfactant; a lipid-protein mixture coats the inside of the 
lung and eases the lung expansion during respiration (West, 2012). Despite this knowledge, 
as will be described in more details later in this chapter, a comprehensive analysis is 
lacking. Therefore, in this thesis, we have utilized a rat model of FGR towards: i) to study 
lung function and the surfactant system in the neonatal period (chapter 2) and ii) examine 
the pulmonary response to an inflammatory insult in adult life (chapter 3) in both male and 
female offspring.  
The objective of the first chapter is to provide an overview of the current state of knowledge 
on Lung development and function, fetal growth restriction effect on the lung development, 
the pulmonary surfactant, surfactant deficiency, and lung injury. Subsequently, the impact 
of sepsis, as the most prevalent inflammatory insult, on the lung will be reviewed. Finally, 
I will discuss FGR focusing on the known information about its effects on the pulmonary 
system. 
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1.2. Lung Development 
To ultimately understand the effects of fetal growth restriction on the lung, it is important 
to first understand normal lung development. Overall, lung development is a series of 
tightly regulated processes beginning in the embryo and continuing during the postnatal 
life. Lung development is divided into three different stages; 1) the embryonic period, 2) 
the fetal period, and 3) postnatal lung development (for detailed review see DiFiore & 
Wilson, 1994 and Schittny, 2017). Lung organogenesis in humans and rats occurs through 
the embryonic period between week 4-7 and day 11-13 of embryonic period; this includes 
formation of the two lung buds which then is followed by the formation of the major 
airways. During fetal period, there is a repetitive process of formation and branching of the 
distal airways for both rats and human. This is followed by the first appearance air-blood 
barrier and the pulmonary surfactant (a lipoprotein complex that facilitates the expanding 
of the lung) in both species before birth. Beginning of the alveolarization (the process by 
which the alveoli, the main pulmonary gas-exchange units, are formed) is one of the major 
differences in the lung development between rats and human. In humans, the first alveolar 
spaces form in the last trimester of pregnancy, while in rats, it begins at postnatal day 7-
21. The process of pulmonary development in both species continues until young adulthood 
with continuous increasing the alveolar spaces and microvascular maturation (Burri, 1992; 
Schittny, Mund, & Stampanoni, 2008). 
 1.3. The Effect of Sexual Dimorphism on the Lung Development 
There is evidence from human and animal studies that there are sexual dimorphisms in the 
regulation of lung development during the fetal and postnatal period (Carey et al., 2007; 
DiFiore & Wilson, 1994; Hibbert et al.,1995; Joshi & Kotecha, 2007; Milewich et al.,1986; 
Sekhon et al., 1999; Simard, Provost, & Tremblay, 2006; ). During fetal period, one such 
difference is a higher degree in lung alveolarization and earlier surge in surfactant content 
in females compared to males in both humans (Fleisher et al., 1985) and animal models 
(Provost, Simard, & Tremblay, 2004; Torday & Nielsen, 1987). It has been shown that 
there is higher degree of maturation in surfactant phospholipid profile in the last trimester 
of a normal pregnancy in healthy females compared to healthy males (Becklake & 
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Kauffmann, 1999; Fleisher et al., 1985). Throughout the postnatal life, the most obvious 
developmental difference between males and females is that lungs of females are smaller 
in size than males (Thurlbeck, 1982). However, the ratio of alveolar numbers and area to 
body mass is higher in females compared to males (Carey et al., 2007; Massaro, 2006). 
Despite all these differences between males and females, there are no significant effects on 
pulmonary physiological measurements between sexes in healthy individuals throughout 
life.  
1.4. Fetal Growth Restriction Effect on the Lung Development 
An important factor that can affect the lung development is alterations in the intra-uterine 
environment. One such example is fetal growth restriction (FGR), which is defined as small 
for gestational age (Mamelle, Cochet, & Claris, 2001; Sohi et al., 2011). Common factors 
results in FGR are oxygen and maternal or fetal nutrient deficiencies which can induce 
ineffective prenatal and postnatal lung development and maturation mostly in a sex-
specific manner (Bose et al., 2009; Harding & Maritz, 2012; Winick & Noble, 1966). 
Previous animal studies showed that neonate rats with FGR had reduced pulmonary 
alveolarization and vessel growth and thickening of the distal airways compared to controls 
(Chen, Wang, & Su, 2004; Rozance et al., 2011). The same results for reduced 
alveolarization was observed in another study that was done by Maritz et al., in 2001; they 
showed that placental insufficiency-induced FGR resulted in decreased alveolarization and 
airspace volume in sheep offspring during infancy and adulthood. These developmental 
impairments can have consequences on the lung function which is a main focus of this 
thesis (chapter 2) and will be discussed in following section.  
1.5. Lung Function 
The primary function of the lung is the process of gas exchange. During breathing, inhaled 
air enters the lungs and reaches the alveoli at the peripheral site of the lung. Oxygen 
diffuses rapidly through the blood-gas barrier into the blood in the capillaries while carbon 
dioxide diffuses out from the blood to the alveoli down its concentration gradient. 
Eventually, carbon dioxide is expired out of the body during exhalation (Diaz et al., 1997; 
West, 1977). To allow for efficient gas exchange the lung has several essential anatomical 
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and mechanical properties. These anatomical features include repeated branching of the 
airways and an inner large surface area (~50-100 m2) available for gas diffusion. 
Furthermore, proximity of an extended network of blood capillaries wrapped around the 
alveoli and presence of a thin air-blood barrier at the alveolar level facilitate the process of 
gas exchange through the alveolar epithelial wall (Ward & Nicholas, 1984).  
In addition to the lung structure, the process of gas exchange, also, depends on the 
mechanical features of the lung and thoracic cavity in which the lungs are located. 
Inspiration occurs through the contraction of the inspiratory muscles, the diaphragm and 
external intercostal muscles. The contraction of these  muscles causes an increase in the 
size of the thoracic cavity generating a pressure gradient to a sub-atmospheric value that 
allows inflow of volumes of air (Grinnan & Truwit, 2005). The expiration process occurs 
when the inspiratory muscles relax, which produce a positive alveolar pressure compared 
to the pressure of the external environment helping the movement of air back into the 
atmosphere (West, 2012). 
In addition to respiratory muscles, there are other mechanical aspects inside the lung that 
affect the breathing process. Two critical aspects of lung mechanics are compliance and 
airway resistance. Compliance refers to the work required to expand lung surface area 
during inhalation. There are two main factors can affect lung compliance: the elasticity 
(stiffness) of the lung tissue and the surface tension arising from the liquid lining the 
alveolar inner surface area (will be discussed in further details in the following sections). 
Increased airway resistance in some pulmonary disease (such as asthma) may increase 
work of breathing. However, in a healthy lung, the effect of airway resistance, relative to 
tissue elasticity and alveolar surface tension, on work of breathing is negligible 
(Sidebotham & Le Grice, 2007).  
1.5.1. Airway Resistance 
Airway resistance is the resistance to the flow of air through the respiratory tract during 
inhalation and expiration (West, 2012). Total airway resistance is the pressure difference 
between mouth and the alveoli, divided by airflow. Airway resistance is determined by the 
diameter of the airways and the velocity of the air flow using the following equation, where 
` 
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ΔP is the pressure difference (cmH2O) driving airflow and v is the velocity difference 
(ml/s).   
Airway Resistance =  𝚫𝐏𝒗  
Clinical analysis has shown that airway resistance can be affected by sex (Becklake & 
Kauffmann, 1999; Mead, 1980). In humans, new born females have higher ratio of large 
to smaller airways. This results in having higher conductance and flow rates in female 
infants compared to males. These differences are also observed until adulthood where 
larger proximal airways for females during deep breathing results in higher conductance 
compare to males (Becklake & Kauffmann, 1999). Despite these differences, in healthy 
individuals, the contribution of airway resistance to the whole respiratory resistance and 
work of breathing is negligible. However, narrowing of the proximal airways, as a result 
of some diseases (i.e., obstructive airway disease) can result in airway resistance in a sex-
dependent manner (with males more affected), which in turn may impact the work of 
breathing and the time required for inhalational and deflation (Crouse & Laine-Alava, 
1999). Furthermore, experimental and clinical studies have shown that FGR is associated 
with impaired proximal airway function in neonate and adults (Dezateux et al., 2004; Joss-
Moore et al., 2011). 
1.5.2. Lung Compliance 
Lung compliance is defined as the expandability of the lungs and its ability to inflate during 
inhalation (Grinnan & Truwit, 2005)  and is determined using the following equation, 
where ΔV is the change in volume (mL) and ΔP is the change in pressure (cmH2O):   
Compliance=  𝚫𝐕𝚫𝐏 
Two key factors impact the lung compliance are resistant force produced by elastic recoil 
of the lung tissues (tissue stiffness) and the surface tension generated at the alveolar air-
liquid interface (Lindahl et al., 1997; Weibel, 2011). Lung elastic recoil is the tendency of 
lung parenchyma to recoil to the resting volume after expanding which arises from lung 
extracellular matrix components most importantly collagen (stiff) and elastin (stretchy) 
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fibers (Carey et al., 2007; Simard et al., 2006). Changes in the composition and/or 
orientation of the extracellular matrix components can alter the pulmonary compliance 
(Andreassen et al., 2010). As mentioned above, surface tension is the other factor that 
affects lung compliance and it is the result of the attractive forces between water molecules 
at the alveolar air-liquid interface. In a healthy lung, alveolar surface tension is regulated 
and maintained at lower values by the presence of surfactant lipid-protein complex secreted 
into the air-space by alveolar type II (ATII) cells (Ward & Nicholas, 1984).  
Opposite to airway resistance, there has not been strong clinical or experimental evidence 
indicating significant differences in pulmonary compliance between healthy males and 
females throughout life (Colebatch, Ng, & Nikov, 1979). Although not been studied 
comprehensively, it has been shown that neonates and adult rat with FGR, induced by 
maternal calorie restriction, had lower lung compliance compared to controls (males only 
included) (Rehan et al., 2012). The results of the only study (Albion, 2011) assessed 
potential sex-based differences of FGR effects on the lung function showed reduced lung 
compliance in only FGR female mice at early life. Based on these studies, there is evidence 
indicating a sex-dependent FGR impact on the lung function. As mentioned before, 
surfactant system directly contributes to regulation of lung compliance. Therefore, reduced 
lung compliance can be implicated in surfactant deficiency and/or inhibition of its 
biophysical function.  
1.6. The Pulmonary Surfactant System 
As mentioned above, pulmonary surfactant has a big impact on maintaining normal lung 
mechanics by reducing the alveolar surface tension. Impairments of the surfactant system, 
such as changes to the surfactant composition and biophysical functions, have been known 
as important contributors to pathogenesis and development of different pulmonary 
complications (Zuo et al., 2008). The surfactant composition and biophysical properties 
will be discussed in the next sections. 
1.6.1. Extracellular Surfactant Composition 
The composition of surfactant has been conserved across different mammalian species; 
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(Orgeig & Daniels, 2001;Veldhuizen et al., 1998) surfactant complex is composed of 
phospholipids ~80-90% by mass (such as phosphatidylcholine), neutral lipids ~3-10% 
(mainly cholesterol), and surfactant-associated proteins (SP-A, SP-B, SP-C, and SP-D) (5-
10%) as well as some other (mostly serum-derived) proteins (Lopez-Rodriguez & Pérez-
Gil, 2014).  
The most abundant surfactant phospholipid component is dipalmitoyl phosphatidylcholine 
(DPPC), a saturated lipid that contributes ~40-50% of the total surfactant phospholipid 
content. DPPC is the main contributor to minimizing surface tension to near zero during 
exhalation (Yu et al., 2004). Surfactant proteins include the small hydrophobic protein, SP-
B and SP-C, that contribute directly to surfactant surface activity, and the hydrophilic 
proteins, SP-A and SP-D, play significant roles in surfactant metabolism and innate 
immune defense (for detailed review see Lopez-Rodriguez & Pérez-Gil, 2014). Proper 
proportion of surfactant lipids and proteins and interactions between these constituents are 
essential for maintaining the surfactant reducing surface tension ability (Mander et al., 
2002). 
1.6.2. Extracellular Surfactant Metabolism  
Surfactant lipids and associated proteins are produced and exocytosed into the alveolar 
space by alveolar type II cells (ATII). The majority of intracellular surfactant is assembled 
into organelles called lamellar bodies (LB) within ATIIs. Upon stimulation, for instance 
by cyclic stretch, the organelles relocate to the apical membrane of ATIIs, where they 
release surfactant into the extracellular alveolar space by exocytosis (Schmitz & Müller, 
1991).  
The extracellular surfactant can be collected by flushing the lungs with saline and 
collecting the liquid. This process is called bronchoalveolar lavage. In vitro, the isolated 
alveolar lavage can be separated into two subfractions by centrifugation. The dense 
structures including surface-active components of surfactant called large aggregates (LA) 
and lighter surfactant vesicles are called small aggregates (SA). Previous studies showed 
some differences in the structure of these surfactant subfractions; LA had lipo-protein 
structures such as LBs, tubular myelin, and surfactant-associated proteins (SP-A, SP-B, 
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SP-C, and SP-D) while these organized structures did not present in SA (Veldhuizen et al., 
1994). 
After being secreted into the alveolar space LBs undergo reorganization into structures 
called tubular myelin; a network structure adsorbed to the air-liquid interface during 
inhalation where it forms a surface-active film (Figure 1.1) (Veldhuizen et al., 1994). After 
being adsorbed to the interface, LA contributes to maintaining alveolar stability by 
reducing alveolar surface tension arising at the air-liquid interface. During breathing 
cycles, changes in the surface area is associated with conversion of LA into SA. Ultimately, 
SA is dissociated from the film and is either uptaken and recycled mostly by ATII cells or 
cleared and degraded within alveolar macrophages by phagocytosis (Günther et al., 2001). 
There has not been clinical or experimental evidence indicating significant sex differences 
in extracellular surfactant levels between healthy individuals throughout life. However, 
differences have been observed in the extracellular surfactant levels in human neonates (50 
to 100mg/Kg body weight) compared to adults (5-10mg/kg body weight) (Fidanovski et 
al., 2005; Hamm, Kroegel, & Hohlfeld, 1996; Jobe & Ikegami, 1987; Runge & Patterson, 
2007). It is suggested that the large surfactant pool sizes at birth is nescessary to fiacilitate 
opening of the lungs upon the transition to the air-breathing environment. 
There have been previous animal studies which measured levels of specific surfactant 
lipids or lipo-proteins in lung tissues (Chen et al., 2004; Gortner et al., 2005; Sutherland et 
al., 2012). Chen et al, in 2004, showed that in a rat model of FGR, induced by 50% maternal 
calorie restriction, there was a reducton in the level of intracellular saturated surfactant 
phospholipids in FGR offspring. Another study showed reductions in the expression levels 
of surfactant lipid-proteins in lung tissues at late gestation in mice fetuses with FGR 
(induced by hypoxia) (Gortner et al., 2005). These limited studies did not assess whether 
these changes resulted in the altertation of the extracellular surfactant metabolism. Also, 
there are no previous studies examining the FGR effect on the surafactant metabolism 
during the adulthood; this will be discussed in chapter 3.  
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Figure 1. 1. Surfactant Metabolism. Surfactant lipo-protein complex is synthesized within 
alveolar type II (ATII) cells, and then stored in lamellar bodies (LB). Upon the cellular 
stimulation, LBs are exocytosed into the liquid hypophase where they unravel and form 
tubular myelin which then adsorbs into the interface to form a surfactant film. During 
expansion-compression cycles LA are metabolized into SA which are taken up by ATII 
cells or cleared by alveolar macrophages (AM).  
1.6.3. Surfactant Function 
As mentioned in previous section, pulmonary surfactant reduces the alveolar surface 
tension at the air-liquid interface. In the absence of surfactant, under the surface of a polar 
liquid, attraction forces of individual molecules pull on each other equally in all directions 
resulting in a net force of 0. At the surface of an air-liquid interface however, the net 
attractive forces between molecules is downward letting the water molecules to compress 
more tightly compared to the molecules inside the aqueous phase. This results in forming 
stronger bonds at the surface (surface tension) that resists deformation.  In the lung, a high 
surface tension can increase work of breathing during inhalation. Also, this can cause less 
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alveolar stability during lung compression which can promote alveolar collapse and, thus, 
reduction in surface area available for gas exchange (Lopez-Rodriguez & Pérez-Gil, 2014).  
In the lung, the presence of surfactant film at the air-liquid interface contributes to reducing 
the surface tension resistant force and increasing alveolar stability (Figure 1.2). This 
happens through adsorption and increasing the concentration of the surfactant lipid-protein 
components into the interface. Upon adsorption, these components displace the water 
molecules and, ultimately, form the interfacial surface-active film (Goerke, 1998; 
Possmayer et al., 2010). When the surfactant phospholipid molecules entirely replace the 
water the surface tension of water would be reduced from ~70mN/m to an equilibrium 
surface tension of ~23–24mN/m (at 37ºC) (Lopez-Rodriguez & Pérez-Gil, 2014).   
 
Figure 1. 2. Forming the interfacial surfactant film. Through the adsorption process, 
surfactant replaces the water molecules and reduced the surface tension from ~70mN/m to 
an equilibrium surface tension of ~23–24mN/m. At lower volumes, with surfactant present, 
lateral compression causes surfactant phospholipid molecules move closer together making 
the surface tension further decrease, thereby, causes more alveolar stabilization and 
prevention of lung collapse (γ: surface tension). 
  
To stabilize the lung, surfactant should maintain its lowering surface tension properties 
during breathing cycles. It means concentration of surfactant components should be 
efficiently regulated at the surfactant film during compression-expansion cycles. During 
exhalation, lateral compression of surfactant film is a mechanism allows alveolar 
stabilization by approaching a surface tension near 0mN/m (Lopez-Rodriguez & Pérez-
- Surfactant
γ =70mN/m
+ Surfactant
γ =22-24mN/m
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Compression
Expansion
Lower Pressure 
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Gil, 2014). The lateral compaction of the interfacial film is enhanced through sufficient 
elevated concentration of saturated DPPC; their saturated acyl chains can get tightly 
compressed with minimum interactions from neighbor phospholipid acyl chains (Lopez-
Rodriguez & Pérez-Gil, 2014; Possmayer et al., 2010). Concentration of saturated DPPC 
can further achieved by exclusion of more fluid lipids, such as unsaturated phospholipids 
and cholesterol, from the film. This allows to achieve the minimum surface tension near 
0mN/m and  therefore more alveolar stability, at the at maximum compression (end of 
deflation) (Keating et al., 2012; Possmayer et al, 2001) 
During inhalation, increases in the interfacial film surface area results in a reduction of 
phospholipid concentration and therefore surface tension increases. An efficient film re-
expansion is achieved by immediate selective re-insertion of the protein-lipid complexes, 
especially saturated DPPC, from the surfactant reservoir below the interface back into the 
surfactant film upon initiation of lung expansion (for more details see Baoukina & 
Tieleman, 2011; Keating et al., 2012; Pérez-Gil & Keough, 1998). 
There has been no study indicating sex differences in surfactant biophysical function 
throughout life. Furthermore, no clinical or experimental study have previously assessed 
the effect of FGR on surfactant biophysical function during the early life or adulthood. In 
chapter 2, in addition to lung compliance and surfactant phospholipid measurements, 
surfactant biophysical analysis was performed on extracellular LA surfactant of FGR 
offspring throughout the lactation period. The surfactant was collected through the lavage 
process and its biophysical measurements was performed using a technique called 
constrained sessile drop surfactometer, which is explained in the section below. 
1.7. Analysis of Surfactant Biophysical Function 
The in vivo assessment of surfactant function is difficult. Therefore, common methods to 
study the surfactant function include removing of the extracellular surfactant by lavaging 
the lung and measuring the surfactant functions in vitro (Zuo et al., 2008). In this thesis, to 
perform the in vitro surfactant function a constrained sessile drop surfactometer (CSD) was 
used (L. M. Y. Yu et al., 2004). The CSD’s features that make it an ideal tool to measure 
the surfactant function are: i) for precise assessments, unlike other methods, very low 
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sample volumes are needed (9-10µl), ii) the environmentally control chamber allows to 
replicate lung temperature and humidity, and, finally, iii) dynamic compression-expansion 
of samples at different frequencies allows to mimic human breathing (L. M. Y. Yu et al., 
2004). A schematic diagram of a CSD we used in this thesis (used in chapter 2) is shown 
in Figure 1.3.  
Surfactant surface tension after adsorption and surface tension reducing ability during 
compression-expansion cycles can be assessed on the CSD. The CSD consists of a 
stainless-steel pedestal which located in an environmentally controlled chamber at 37°C. 
To perform the biophysical assessments, a small droplet (9-10µl) of LA surfactant is 
deposited on top of the pedestal. The droplet is allowed to equilibrate for ~2min during 
which LA phospholipids absorbed to the air-liquid interface. The droplet is then exposed 
to compression-expansion cycles by the water pressure that is controlled with a syringe 
that directs the water to the top of the pedestal below the LA droplet. During the 
compression cycles, while a light source illuminates the droplet, a microscopic camera 
takes hundreds of images of the illuminated LA droplet. The images are recorded and later 
are analyzed for surfactant biophysical measurements by using an Axisymmetric Drop 
Shape Analysis (ADSA) software (Kalantarian et al., 2011). 
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Figure 1. 3. A schematic diagram of the constrained sessile drop surfactometer (CSD). (A) 
This setup allows to precisely assess the surfactant function using a small volume of LA 
sample (9-10µl) on a pedestal, in an environmentally control chamber. The pedestal is 
connected to a computer-controlled syringe for dynamic compression and expansion 
cycling; mimicking breathing cycles. During the cycling, a digital camera takes and records 
images of the droplet. (B) Surfactant function is assessed by image analysis which is based 
on the shape and surface area of the droplet (Kalantarian, Saad, & Neumann, 2013) (γ: 
surface tension). 
 1.8. Clinical Significance of Surfactant 
The importance of surfactant metabolism and biophysical function for a normal healthy 
lung function is best illustrated in patients with respiratory diseases such as neonatal 
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respiratory distress syndrome and the acute respiratory distress syndrome in adults.  
1.8.1. Neonatal Respiratory Distress Syndrome (NRDS)  
NRDS is a disease of infants and is characterized by immature lung development and 
surfactant deficiency. The infants experience reduced lung compliance, increased work of 
breathing, alveolar collapse, and reduce blood oxygenation (Avery & Mead, 1959; 
Brumley, Hodson, & Avery, 1967; Davis, Morley, & Manley, 2012). Previous clinical 
observations showed that there were about 10 times reductions in the total alveolar 
surfactant pool sizes in premature infants with NRDS compared to healthy offspring 
(10mg/Kg in NRDS vs 100mg/Kg body weight in control) (Fidanovski et al., 2005). Also, 
surfactant analysis of infants died from NRDS demonstrated impairments of reducing 
surface tension property compared to infants died from other diseases (Avery & Mead, 
1959). The importance of the pulmonary surfactant has been shown by adverse respiratory 
outcomes caused by surfactant deficiency in NRDS patients and subsequently alleviating 
these deleterious outcomes by instillation of exogenous surfactant formulations within the 
lung lumen of NRDS patients (Enhorning et al., 1985; Hallman et al., 1985; Liechty et al., 
1991). In spite of applying surfactant replacement therapy and the implementation of high 
technology, NRDS is still a common cause of mortality among the neonates with surfactant 
deficiencies (Kamath et al., 2011). 
1.8.2. Acute Respiratory Distress Syndrome (ARDS) 
In adults, surfactant alteration has been consistently illustrated in patients with ARDS, 
which is defined by severe lung dysfunction occurs after initiating direct (i.e., gastric acid 
aspiration) or indirect (i.e., sepsis) (Akella & Deshpande, 2013; Frerking, Günther, Seeger, 
& Pison, 2001; R. A. Veldhuizen, McCaig, Akino, & Lewis, 1995) insults to the lung. The 
pathophysiology associated with ARDS includes acute systemic and pulmonary 
inflammation and pulmonary edema. These alterations can result in dysregulated surfactant 
metabolism and inhibition of LA biophysical function (Gregory et al., 1991; Günther et al., 
1996; Günther et al., 2001; Schmidt et al., 2007; Veldhuizen et al., 1995; Ware & Matthay, 
2000). The ultimate results of surfactant inhibition are reduced lung compliance and 
hypoxemia, the development of severe lung injury and, ultimately, in critically ill patients, 
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lung failure and death. Due to the lack of effective pharmacotherapies the mortality 
associated with ARDS is high in the ICU (~40% worldwide). One of the common reasons 
for the failure of therapeutic approaches is that different types of initiating insults can affect 
different systemic and pulmonary intracellular pathways with different severity. 
Furthermore, patient-specific characteristics can affect the complexity and severity of the 
disease. Therefore, one way to interfere with the adverse outcomes of the disease can be 
identifying the factors that influence the progression of the pulmonary alterations due to 
common etiologies of ARDS (i.e. sepsis).  
1.8.3. Sepsis-Induced ARDS 
Sepsis is defined as a dysregulated host immune response to a systemic infection and is the 
most common etiology of severe lung injury and ARDS in adults (with males more 
affected) (Fein & Calalang-Colucci, 2000; Hudson et al., 1995; Zellweger et al., 1997). 
The acute systemic inflammation often causes multi-organ dysfunction in the setting of 
severe sepsis including lung as one of the first organs adversely affected (Shorr et al., 
2006).  
Previous clinical and animal studies showed that sepsis-induced lung injury was associated 
with reductions in the total surfactant content (Huang et al.,2005; Malloy et al., 1997; Pison 
et al., 1990). Although surfactant replacement therapies have shown significant beneficial 
impacts in infants with NRDS it has unfortunately failed to show any beneficial clinical 
effect in adults with sepsis-induced ARDS (Spragg, 2002). Also, no other clinical therapies 
have been successfully developed to benefit all these patients. One of the other main 
reasons for high mortality in patients with sepsis-induced ARDS is that the diagnosis of 
the disease progression is possible when the patient is beyond the time frame for receiving 
efficient therapies (Shaver et al., 2017). Therefore, as the most common cause of ARDS, 
identifying risk factors that predispose the septic individuals at higher risks of the 
development of pulmonary impairments would be beneficial.  
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1.8.4. Fetal Growth Effect on the Sepsis-Induced Pulmonary Response 
Different patient-specific factors have impacts on the incidence of sepsis and its associated 
pulmonary pathophysiological outcomes (Danai et al., 2006). There is some evidence that 
fetal growth restriction (FGR) may be one such potential factor which is defined as small 
for gestational age (Barker et al., 1991; Hoo et al., 2004; Rueda-Clausen, Morton, & 
Davidge, 2009).  
Clinical and animal studies indicate that FGR is associated with a variety of adult on-set 
diseases (with males more affected) such as diabetes, cardiovascular diseases, chronic 
pulmonary hypertension, and chronic systemic inflammation (Barker et al., 1991; Karadag 
et al., 2009; Murki & Deepak, 2014; Real et al., 2010; Vega et al., 2016; Wong et al., 2008) 
There are underlying shared mechanism between these morbidities and sepsis-induced 
ARDS, such as chronic inflammatory responses and ER and oxidative stress (Lv et al., 
2013; Maritz et al., 2004; Vega et al., 2016). Despite all this evidence, the impact of FGR 
on the septic pulmonary response has not been studied in great details.  
1.8.5. Analysis of FGR Effect on Sepsis-Induced Pulmonary Response  
To study sepsis and FGR there have been some animal models developed with some 
advantages and disadvantages (Joss-Moore et al., 2011; Maritz et al., 2004; Swanson & 
David, 2015). For our study, we used rats as experimental species due to some specific 
features such as: i) rats’ surfactant system and lung function have been extensively assessed 
in many previous studies, including our lab (Huang et al., 2005; Malloy et al., 1997; Orgeig, 
Barr, & Nicholas, 1995; Wichert et al., 2000) , ii) rats can be used as a clinically relevant 
animal model in the setting of both FGR and sepsis (Petry, Ozanne, & Hales, 2001) (have 
been, further, discussed below), iii) it is a, relatively, low cost animal model with high 
reproduction rates, iv) the relative large size of rats allows for easy handling, breeding, 
instrumentation, and obtaining enough samples even at the neonatal period. Given that 
there is a sexual dimorphism in developing sepsis-induced pulmonary dysfunction and 
FGR-adult onset-diseases, all the treatments and experimental analysis were applied to 
both male and female rats.  
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To induce FGR, we used an isocaloric maternal low protein diet (LP) during pregnancy-
lactation period. This model has some features which make it suitable for the purpose of 
this study, such as i) LP newborn rats display FGR characteristics (Petry, Ozanne, & Hales, 
2001; Snoeck et al, 1990), ii) LP offspring manifest various clinical adult-onset morbidities 
such as hypertension, hypercholesterolemia, and insulin resistance, iii) LP is a relevant 
animal model of human placental dysfunction-induced FGR (the common etiology in 
Canada) (Crosby, 1991), and, finally, iv) compared to other FGR models like hypoxia or 
utero-placental intervention, LP is less technically demanding and accompanied with 
significantly less maternal mortality and fetal resorption (Hayashi & Dorko, 1988). 
Sepsis was induced in rats by fecal-induced peritonitis (FIP). Some features of FIP that 
make it  a proper model to study sepsis are i) consistently mimicking clinical septic-
associated pathophysiological outcomes (Vincent et al., 2009), ii) easy controlling of 
disease severity by adjusting the injecting dose of fecal slurry, iii) no need for surgery and 
post-surgical recovery procedure, and iv) no need for general anesthesia; it suppress 
breathing and can affect surfactant metabolism (Petrov & Lyubarskii, 1966; Saraswat, 
2015).  
The sepsis effect in FGR rats was investigated by: i) measuring levels of systemic and 
pulmonary inflammatory responses, ii) measuring the extracellular pulmonary surfactant 
levels, and iii) a preliminary histological assessment. 
 1.9. Rationale and Hypothesis  
The proper lung mechanics and the process of gas exchange are directly dependent on the 
surfactant function. At the early life, impairments of the lung development may result in 
significant persisting alterations of the surfactant system with progression of several 
associated adverse impacts. From previous animal studies, there are some preliminary 
indications that FGR has potential effects on the lung development and the surfactant 
system of neonates with life-lasting consequences. Furthermore, clinical and experimental 
studies demonstrated that FGR adult-onset morbidities may predispose individuals to the 
development of surfactant impairments and lung injury in response to an insult, such as 
sepsis, in a sex-dependent manner. Based on this knowledge and lack of effective therapies 
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for sepsis-induced pulmonary complications, in-detail analysis the potential FGR 
pulmonary outcomes may help to identify and, ultimately, interfere with its clinical 
associated risks. 
I had two hypotheses:   
Hypothesis 1– FGR induced by maternal protein restriction contributes to the alterations 
of lung mechanics and of the surfactant system in a sex-dependent manner during the 
neonatal period (Chapter 2). 
Hypothesis 2– In response to sepsis, FGR induced by maternal protein restriction 
contributes to the alterations of the surfactant system in adults in a sex-dependent manner 
(Chapter 3). 
I had two objectives: 
Objective 1– To examine the lung mechanics and amounts and function of the pulmonary 
surfactant in a rat model of FGR induced by a low maternal protein diet during the neonatal 
period (Chapter 2).  
Objective 2– To examine the effects of FGR induced by maternal protein restriction on 
the amounts of pulmonary surfactant and development of lung injury in response to sepsis 
in adults (Chapter 3).  
 
1.10. Reference List: 
Akella, A., & Deshpande, S. B. (2013). Pulmonary surfactants and their role in 
pathophysiology of lung disorders. Indian Journal of Experimental Biology, 51(1), 5–
22. 
Albion, C. D. (2011). Fetal Growth Restriction: Molecular mechanisms and long-term 
outcome, PhD Thesis, The University of Western Ontario.  
Andreassen, S., Steimle, K. L., Mogensen, M. L., Bernardino de la Serna, J., Rees, S., & 
` 
 20 
Karbing, D. S. (2010). The effect of tissue elastic properties and surfactant on alveolar 
stability. Journal of Applied Physiology, 109(5), 1369–1377.  
Avery, M., & Mead, J. (1959). Surface properties in relation to atelectasis and hyaline 
membrane disease. Am J Dis Child, 97(2), 4515–4515.  
Baoukina, S., & Tieleman, D. P. (2011). Lung surfactant protein SP-B promotes formation 
of bilayer reservoirs from monolayer and lipid transfer between the interface and 
subphase. Biophysical Journal, 100(7), 1678–1687.  
Barker, D. J., Godfrey, K. M., Fall, C., Osmond, C., Winter, P. D., & Shaheen, S. O. (1991). 
Relation of birth weight and childhood respiratory infection to adult lung function and 
death from chronic obstructive airways disease. British Medical Journal , 303(6804), 
671–675. 
Becklake, M. R., & Kauffmann, F. (1999). Gender differences in airway behaviour over 
the human life span. Thorax, 54(12), 1119–1138.  
Bose, C., Van Marter, L. J., Laughon, M., O’Shea, T. M., Allred, E. N., Karna, P., 
Ehrenkranz R.A., Boggess K., & Leviton A. (2009) Extremely Low Gestational Age 
Newborn Study Investigators. Fetal growth restriction and chronic lung disease 
among infants born before the 28th week of gestation. Pediatrics, 124(3), 450-8. 
Brumley, G. W., Hodson, W. A., & Avery, M. E. (1967). Lung phospholipids and surface 
tension correlations in infants with and without hyaline membrane disease and in 
adults. Pediatrics, 40(1), 13–19. 
Burri, P. H. (1992). Postnatal development and growth of the pulmonary microvasculature. 
In Scanning Electron Microscopy of Vascular Casts: Methods and Applications (pp. 
139–156). Boston, MA: Springer US. 
Carey, M. A., Card, J. W., Voltz, J. W., Arbes, S. J., Germolec, D. R., Korach, K. S., & 
Zeldin, D. C. (2007). It’s all about sex: gender, lung development and lung disease. 
Trends in Endocrinology and Metabolism: TEM, 18(8), 308–313.  
` 
 21 
Chen, C. M., Wang, L. F., & Su, B. (2004). Effects of maternal undernutrition during late 
gestation on the lung surfactant system and morphometry in rats. Pediatric Research, 
56(3), 329–335.  
Colebatch, H. J., Ng, C. K., & Nikov, N. (1979). Use of an exponential function for elastic 
recoil. Journal of Applied Physiology, 46(2), 387–393.  
Crosby, W. M. (1991). Studies in fetal malnutrition. American Journal of Diseases of 
Children, 145(8), 871–876.  
Crouse, U., & Laine-Alava, M. T. (1999). Effects of age, body mass index, and gender on 
nasal airflow rate and pressures. The Laryngoscope, 109(9), 1503–1508.  
Danai, P. A., Moss, M., Mannino, D. M., & Martin, G. S. (2006). The epidemiology of 
sepsis in patients with malignancy. Chest, 129(6), 1432–1440.  
Dezateux, C., Lum, S., Hoo, A. F., Hawdon, J., Costeloe, K., & Stocks, J. (2004). Low 
birth weight for gestation and airway function in infancy: exploring the fetal origins 
hypothesis. Thorax, 59(1), 60–66.  
Diaz, O., Iglesia, R., Ferrer, M. I., Zavala, E., Santos, C., Wagner, P. D., Roca J., 
Rodriguez-Roisin, R. (1997). Effects of noninvasive ventilation on pulmonary gas 
exchange and hemodynamics during acute hypercapnic exacerbat ions of chronicobst 
ructive pulmonary Disease. American Journal of Respiratory and Critical Care 
Medicine, 156(16), 1840-1845. 
DiFiore, J. W., & Wilson, J. M. (1994). Lung development. Seminars in Pediatric Surgery, 
3(4), 221-32 
Enhorning, G., Shennan, A., Possmayer, F., Dunn, M., Chen, C. P., & Milligan, J. (1985). 
Prevention of neonatal respiratory distress syndrome by tracheal instillation of 
surfactant: a randomized clinical trial. 76(2), 145–153. 
Fein, A. M., & Calalang-Colucci, M. G. (2000). Acute lung injury and acute respiratory 
distress syndrome in sepsis and septic shock. Critical Care Clinics, 16(2), 289–317.  
` 
 22 
Fidanovski, D., Milev, V., Sajkovski, A., Hristovski, A., Sofijanova, A., & Kojić, L. 
(2005). Mortality risk factors in premature infants with respiratory distress syndrome 
treated by mechanical ventilation. Srpski Arhiv Za Celokupno Lekarstvo, 133(1–2), 
29–35.  
Fleisher, B., Kulovich, M. V, Hallman, M., & Gluck, L. (1985). Lung profile: sex 
differences in normal pregnancy. Obstetrics and Gynecology, 66(3), 327–330.   
Frerking, I., Günther, A., Seeger, W., & Pison, U. (2001). Pulmonary surfactant: functions, 
abnormalities and therapeutic options. Intensive Care Medicine, 27(11), 1699–1717. 
Goerke, J. (1998). Pulmonary surfactant: functions and molecular composition. Biochimica 
et Biophysica Acta- Molecular Basis of Disease, 1408(2–3), 79–89.  
Gortner, L., Hilgendorff, A., Bähner, T., Ebsen, M., Reiss, I., & Rudloff, S. (2005). 
Hypoxia-induced intrauterine growth retardation: Effects on pulmonary development 
and surfactant protein transcription. Biology of the Neonate, 88(2), 129-135. 
Gregory, T. J., Longmore, W. J., Moxley, M. A., Whitsett, J. A., Reed, C. R., Fowler, A. 
A., Hudson L.D., Maunder R.C., & Hyers, T. M. (1991a). Surfactant chemical 
composition and biophysical activity in acute respiratory distress syndrome. Journal 
of Clinical Investigation, 88(6), 1976–1981.  
Grinnan, D. C., & Truwit, J. D. (2005). Clinical review: Respiratory mechanics in 
spontaneous and assisted ventilation. Critical Care, 9(5), 472–484.  
Günther, A., Ruppert, C., Schmidt, R., Markart, P., Grimminger, F., Walmrath, D., & 
Seeger, W. (2001). Surfactant alteration and replacement in acute respiratory distress 
syndrome. Respiratory Research, 2(6), 353–364. 
Günther, A., Siebert, C., Schmidt, R., Ziegler, S., Grimminger, F., Yabut, M., Temmesfeld 
B., Walmrath D., Morr H., Seeger, W. (1996). Surfactant alterations in severe 
pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. 
American Journal of Respiratory and Critical Care Medicine, 153(1), 176–184.  
` 
 23 
Hallman, M., Merritt, T. A., Jarvenpaa, A.L., Boynton B., Mannino F., Gluck L., Moore 
T., & Edwards D. (1985). Exogenous human surfactant for treatment of severe 
respiratory distress syndrome: A randomized prospective clinical trial. The Journal of 
Pediatrics, 106(6), 963–969.  
Hamm, H., Kroegel, C., & Hohlfeld, J. (1996). Surfactant: A review of its functions and 
relevance in adult respiratory disorders. Respiratory Medicine, 90(5), 251–270.  
Harding, R., & Maritz, G. (2012). Maternal and fetal origins of lung disease in adulthood. 
Seminars in Fetal and Neonatal Medicine, 17(2), 67–72.  
Hayashi, T. T., & Dorko, M. E. (1988). A rat model for the study of intrauterine growth 
retardation. American Journal of Obstetrics and Gynecology, 158(5), 1203–1207.   
Hibbert, M., Lannigan, A., Raven, J., Landau, L., & Phelan, P. (1995). Gender differences 
in lung growth. Pediatric Pulmonology, 19(2), 129–134.   
Hoo, A.F., Stocks, J., Lum, S., Wade, A. M., Castle, R. A, Costeloe, K. L., & Dezateux, C. 
(2004). Development of lung function in early life: influence of birth weight in infants 
of nonsmokers. American Journal of Respiratory and Critical Care Medicine, 170(5), 
527–533.  
Huang, W., McCaig, L. A., Veldhuizen, R. A. W., Yao, L. J., & Lewis, J. F. (2005). 
Mechanisms responsible for surfactant changes in sepsis-induced lung injury. 
European Respiratory Journal, 26(6), 1074–1079.  
Hudson, L. D., Milberg, J. A., Anardi, D., & Maunder, R. J. (1995). Clinical risks for 
development of the acute respiratory distress syndrome. American Journal of 
Respiratory and Critical Care Medicine, 151(21), 293–301.  
Jobe, A., & Ikegami, M. (1987). Surfactant for the treatment of respiratory distress 
syndrome. American Review of Respiratory Disease, 136(5), 1256–1275.  
Joshi, S., & Kotecha, S. (2007). Lung growth and development. Early Human 
Development, 83(12), 789–794.  
` 
 24 
Joss-Moore, L. A., Wang, Y., Ogata, E. M., Sainz, A. J., Yu, X., Callaway, C. W., 
McKnight, R.A., Albertine K. H., & Lane, R. H. (2011). IUGR differentially alters 
MeCP2 expression and H3K9Me3 of the PPARγ gene in male and female rat lungs 
during alveolarization. Birth Defects Research Part A- Clinical and Molecular 
Teratology. 91(8), 672-81.  
Kalantarian, A., Saad, S. M. I., & Neumann, A. W. (2013). Accuracy of surface tension 
measurement from drop shapes: The role of image analysis. Advances in Colloid and 
Interface Science, 199–200, 15–22.  
Karadag, A., Sakurai, R., Wang, Y., Guo, P., Desai, M., Ross, M. G., Torday J.S., & Rehan, 
V. K. (2009). Effect of maternal food restriction on fetal rat lung lipid differentiation 
program. Pediatric Pulmonology, 44(7), 635–644.  
Keating, E., Zuo, Y. Y., Tadayyon, S. M., Petersen, N. O., Possmayer, F., & Veldhuizen, 
R. A. W. (2012). A modified squeeze-out mechanism for generating high surface 
pressures with pulmonary surfactant. Biochimica et Biophysica Acta - Biomembranes, 
1818(5), 1225–1234.   
Liechty, E. A., Donovan, E., Purohit, D., Gilhooly, J., Feldman, B., Noguchi, A., Denson 
S.E., Sehgal S.S., Gross I., & Stevens, D. (1991). Reduction of neonatal mortality 
after multiple doses of bovine surfactant in low birth weight neonates with respiratory 
distress syndrome. Pediatrics, 88(1), 19–28. 
Lindahl, P., Karlsson, L., Hellström, M., Gebre-Medhin, S., Willetts, K., Heath, J. K., & 
Betsholtz, C. (1997). Alveogenesis failure in PDGF-A-deficient mice is coupled to 
lack of distal spreading of alveolar smooth muscle cell progenitors during lung 
development. Development, 124(20), 3943–3953. 
Lopez-Rodriguez, E., & Pérez-Gil, J. (2014). Structure-function relationships in 
pulmonary surfactant membranes: From biophysics to therapy. Biochimica et 
Biophysica Acta - Biomembranes, 1838(6), 1568–1585.  
Lv, Y., Tang, L. L., Wei, J. K., Xu, X. F., Gu, W., Fu, L. C., Du L. Z., Zhang L. Y., & Du, 
` 
 25 
L. Z. (2013). Decreased Kv1.5 expression in intrauterine growth retardation rats with 
exaggerated pulmonary hypertension. American Journal of Physiology-Lung Cellular 
and Molecular Physiology, 305(11), L856–L865.  
Malloy, J., McCaig, L., Veldhuizen, R., Yao, L., Joseph, M., Whitsett, J., & Lewis, J. 
(1997). Alterations of the endogenous surfactant system in septic adult rats. American 
Journal of Respiratory and Critical Care Medicine, 156(2), 617–623.  
Mamelle, N., Cochet, V., & Claris, O. (2001). Definition of fetal growth restriction 
according to constitutional growth potential. Biology of the Neonate, 80(4), 277–285.  
Mander, A., Langton-Hewer, S., Bernhard, W., Warner, J., & Postle, A. (2002). Altered 
phospholipid composition and aggregate structure of lung surfactant is associated with 
impaired lung function in young children with respiratory infections. American 
Journal of Respiratory Cell and Molecular Biology, 27(6), 714–721.  
Maritz, G. S., Cock, M. L., Louey, S., Joyce, B. J., Albuquerque, C. A., & Harding, R. 
(2001). Effects of fetal growth restriction on lung development before and after birth: 
a morphometric analysis. Pediatr Pulmonol, 32(3), 201–210.  
Maritz, G. S., Cock, M. L., Louey, S., Suzuki, K., & Harding, R. (2004). Fetal growth 
restriction Has long-term effects on postnatal lung structure in sheep. Pediatric 
Research, 55(2), 287–295.  
Massaro, D. (2006). Estrogen receptor regulation of pulmonary alveolar dimensions: 
alveolar sexual dimorphism in mice. Lung Cellular and Molecular Physiology, 
290(5), 866–870.  
Mead, J. (1980). Dysanapsis in normal lungs assessed by the relationship between maximal 
flow, static recoil, and vital capacity. The American Review of Respiratory Disease, 
121(2), 339–342. 
Mestan, K. K., & Steinhorn, R. H. (2011). Fetal origins of neonatal lung disease: 
understanding the pathogenesis of bronchopulmonary dysplasia. American Journal of 
Physiology. Lung Cellular and Molecular Physiology, 301(6), 858-859.  
` 
 26 
Milewich, L., Kaimal, V., Shaw, C. B., Johnson, A. R., & And, C. H. (1986). 
Androstenedione metabolism in human lung fibroblasts. The Journal of Steroid 
Biochemistry and Molecular Biology, 24(4), 893-897. 
Murki, S., & Deepak, S. (2014). Intrauterine growth retardation - A Review Article. 
Journal of Neonatal Biology, 3(3), 1-11.  
Orgeig, S., Barr, H. A., & Nicholas, T. E. (1995). Effect of hyperpnea on the cholesterol to 
disaturated phospholipid ratio in alveolar surfactant of rats. Experimental Lung 
Research, 21(1), 157–174.   
Orgeig, S., & Daniels, C. B. (2001). The roles of cholesterol in pulmonary surfactant: 
insights from comparative and evolutionary studies. Comparative Biochemistry and 
Physiology Part A: Molecular & Integrative Physiology, 129(1), 75–89.  
Ozaki, T., Nishina, H., Hanson, M. A., & Poston, L. (2001). Dietary restriction in pregnant 
rats causes gender-related hypertension and vascular dysfunction in offspring. The 
Journal of Physiology, 530(1), 141–152.   
Ozanne, S. E., Martensz, N. D., Petry, C. J., Loizou, C. L., & Hales, C. N. (1998). Maternal 
low protein diet in rats programmes fatty acid desaturase activities in the offspring. 
Diabetologia, 41(11), 1337–1342. 
Pérez-Gil, J., & Keough, K. M. W. (1998). Interfacial properties of surfactant proteins. 
Biochimica et Biophysica Acta - Molecular Basis of Disease, 1408(2–3), 203–217.  
Petrov, V., & Lyubarskii, K. (1966). Effect of general anesthetics on surface activity of the 
lung. Bulletin of Experimental Biology and Medicine, 83(5), 670-672. 
Petry, C. J., Ozanne, S. E., & Hales, C. N. (2001). Programming of intermediary 
metabolism. Molecular and Cellular Endocrinology, 185(1–2), 81–91.  
Pison, U., Obertacke, U., Brand, M., Seeger, W., Joka, T., Bruch, J., & Schmit-Neuerburg, 
K. P. (1990). Altered pulmonary surfactant in uncomplicated and septicemia-
complicated courses of acute respiratory failure. The Journal of Trauma, 30(1), 19–
` 
 27 
26.   
Possmayer, F., Hall, S. B., Haller, T., Petersen, N. O., Zuo, Y. Y., Bernardino de la Serna, 
J., Postle A. D., Veldhuizen R. A., Orgeig S. (2010). Recent advances in alveolar 
biology: Some new looks at the alveolar interface. Respiratory Physiology and 
Neurobiology, 173(2010), 55-64. 
Possmayer, F., Nag, K., Rodriguez, K., Qanbar, R., & Schürch, S. (2001). Surface activity 
in vitro: role of surfactant proteins. Comparative Biochemistry and Physiology. Part 
A, Molecular & Integrative Physiology, 129(1), 209–220.  
Provost, P. R., Simard, M., & Tremblay, Y. (2004). A link between lung androgen 
metabolism and the emergence of mature epithelial type II cells. American Journal of 
Respiratory and Critical Care Medicine, 170(3), 296–305.  
Real, J. M. F., Valdes, S., Manco, M., & Chico, B. (2010). Surfactant Protein D , a marker 
of lung innate immunity , is positively associated. Diabetes Care, 33(4), 847-853. 
Rehan, V. K., Sakurai, R., Li, Y., Karadag, A., Corral, J., Bellusci, S., Xue Y. Y., Belperio 
J., & Torday, J. S. (2012). Effects of maternal food restriction on offspring lung 
extracellular matrix deposition and long term pulmonary function in an experimental 
rat model. Pediatric Pulmonology, 47(2), 162–171. 
Rozance, P. J., Seedorf, G. J., Brown, A., Roe, G., O’Meara, M. C., Gien, J., Tang J. R., 
&Abman, S. H. (2011). Intrauterine growth restriction decreases pulmonary alveolar 
and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro 
in fetal sheep. American Journal of Physiology. Lung Cellular and Molecular 
Physiology, 301(6), 860-71.  
Rueda-Clausen, C. F., Morton, J. S., & Davidge, S. T. (2009). Effects of hypoxia-induced 
intrauterine growth restriction on cardiopulmonary structure and function during 
adulthood. Cardiovascular Research, 81(4), 713–722.  
Runge, M. S., & Patterson, C. (2007). Principles of Molecular Medicine (2nd ed.). New 
Jersy: Springer. 
` 
 28 
Saraswat, V. (2015). Effects of anaesthesia techniques and drugs on pulmonary function. 
Indian Journal of Anaesthesia, 59(9), 557–564.  
Schittny, J. C. (2017). Development of the lung. Cell and Tissue Research, 367(3), 427–
444.  
Schittny, J. C., Mund, S. I., & Stampanoni, M. (2008). Evidence and structural mechanism 
for late lung alveolarization. American Journal of Physiology. Lung Cellular and 
Molecular Physiology, 294(2), L246-54.  
Schmidt, R., Markart, P., Ruppert, C., Wygrecka, M., Kuchenbuch, T., Walmrath, D., & 
Guenther, A. (2007). Time-dependent changes in pulmonary surfactant function and 
composition in acute respiratory distress syndrome due to pneumonia or aspiration. 
Respiratory Research, 8(5), 1–11.  
Schmitz, G., & Müller, G. (1991). Structure and function of lamellar bodies, lipid-protein 
complexes involved in storage and secretion of cellular lipids. Journal of Lipid 
Research, 32(10), 1539–1570. 
Sekhon, H. S., Jia, Y., Raab, R., Kuryatov, A., Pankow, J. F., Whitsett, J. A., & Spindel, 
E. R. (1999). Prenatal nicotine increases pulmonary α7 nicotinic receptor expression 
and alters fetal lung development in monkeys. Journal of Clinical Investigation, 
103(5), 637–647.  
Shaver, C. M., Woods, J., Clune, J. K., Grove, B. S., Wickersham, N. E., McNeil, J. B., 
Shemancik G., Ware LB., Bastarache, J. A. (2017). Circulating microparticle levels 
are reduced in patients with ARDS. Critical Care, 21(1), 1–8.  
Shorr, A. F., Bernard, G. R., Dhainaut, J. F., Russell, J. R., Macias, W. L., Nelson, D. R., 
& Sundin, D. P. (2006). Protein C concentrations in severe sepsis: An early directional 
change in plasma levels predicts outcome. Critical Care, 10(3), 1–8.  
Sidebotham, D., & Le Grice, I. J. (2007). Chapter 1 - Physiology and Pathophysiology. 
Cardiothoracic Critical Care, 3–27. Auckland: Butterworth-Heinemann 
` 
 29 
Simard, M., Provost, P. R., & Tremblay, Y. (2006). Sexually dimorphic gene expression 
that overlaps maturation of type II pneumonocytes in fetal mouse lungs. Reproductive 
Biology and Endocrinology, 4(25), 1–14.  
Snoeck, A., Remacle, C., Reusens, B., & Hoet, J. J. (1990). Effect of a low protein diet 
during pregnancy on the fetal rat endocrine pancreas. Neonatology, 57(2), 107–118.  
Sohi, G., Marchand, K., Revesz, A., Arany, E., & Hardy, D. B. (2011). Maternal protein 
restriction rlevates cholesterol in adult rat offspring due to repressive changes in 
histone modifications at the cholesterol 7 α- hydroxylase promoter. Molecular 
Endocrinology, 25(5), 785–798.  
Spragg, R. G. (2002). The future of surfactant therapy for patients with acute lung injury – 
New requirements and new surfactants. Neonatology, 81(1), 20–24.  
Sugahara, K., Maeda, H., Yamashiro, K.-I., Kohda, H., Okazaki, T., & Morioka, T. (1983). 
Quantification of an apoprotein of pulmonary surfactant in normal and alloxan-
induced diabetic rats by electroimmunoassay. Lung, 161(1), 181–190.  
Sutherland, A. E., Crossley, K. J., Allison, B. J., Jenkin, G., Wallace, E. M., & Miller, S. 
L. (2012). The effects of intrauterine growth restriction and antenatal glucocorticoids 
on ovine fetal lung development. Pediatric Research, 71(6), 689–696.  
Swanson, A. M., & David, A. L. (2015). Animal models of fetal growth restriction: 
Considerations for translational medicine. Placenta, 36(6), 623–630.  
Thurlbeck, W. M. (1982). Postnatal human lung growth. Thorax, 37(8), 564–571.  
Torday, J. S., & Nielsen, H. C. (1987). The sex Difference in fetal lung surfactant 
production. Experimental Lung Research, 12(1), 1–19.  
Vega, C. C., Reyes-Castro, L. A., Rodríguez-González, G. L., Bautista, C. J., Vázquez-
Martínez, M., Larrea, F., Chamorro-Cevallos G. A., Zambrano E., Nathanielsz P. W., 
& Zambrano, E. (2016). Resveratrol partially prevents oxidative stress and metabolic 
dysfunction in pregnant rats fed a low protein diet and their offspring. The Journal of 
` 
 30 
Physiology, 594(5), 1483–1499.  
Veldhuizen, R. A., McCaig, L. A., Akino, T., & Lewis, J. F. (1995). Pulmonary surfactant 
subfractions in patients with the acute respiratory distress syndrome. American 
Journal of Respiratory and Critical Care Medicine, 152(6), 1867–1871.  
Veldhuizen, R. a, Hearn, S. a, Lewis, J. F., & Possmayer, F. (1994). Surface-area cycling 
of different surfactant preparations: SP-A and SP-B are essential for large-aggregate 
integrity. The Biochemical Journal, 300( 2), 519–524.  
Veldhuizen, R., Nag, K., Orgeig, S., & Possmayer, F. (1998). The role of lipids in 
pulmonary surfactant. Biochimica et Biophysica Acta - Molecular Basis of Disease. 
1408(2–3), 90–108.  
Vincent, J. L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin, C. D., Moreno R., 
Lipman J., Gomersall C., Sakr Y., & Reinhart K. (2009). International study of the 
prevalence and outcomes of infection in intensive care units. The Journal of the 
American Medical Association. 302(21), 2323-2329 
Visentin, S., Lapolla, A., Londero, A. Pietro, Cosma, C., Dalfrà, M., Camerin, M., Faggian 
D., Plebani M., & Cosmi, E. (2014). Adiponectin levels are reduced while markers of 
systemic inflammation and aortic remodelling are increased in intrauterine growth 
restricted mother-child couple. BioMed Research International, 2014 (1), 1-11 
Ward, H., & Nicholas, T. (1984). Alveolar type I and type II cells. Australian and New 
Zealand journal of medicine, 14(5), 731–734. 
Ware, L. B., & Matthay, M. A. (2000). The acute respiratory distress syndrome. New 
England Journal of Medicine, 342(18), 1334–1349.  
Weibel, E. R. (2011). Functional morphology of lung parenchyma. In Comprehensive 
Physiology (pp. 89–111). New Jersy: John Wiley & Sons, Inc.  
West, J. B. (1977). State of the art: ventilation-perfusion relationships. The American 
Review of Respiratory Disease, 116(5), 919–943.  
` 
 31 
West, J. B. (2012). Pulmonary pathophysiology : the essentials. Sandiego: Lippincott 
Williams & Wilkins. 
Wichert, P. I., Wiegers, U., Stephan, W., Huck, A., Eckert, P., Riesner, K., & Universit, D. 
(2000). Altered metabolism of phospholipids in the lung of rats with peritonitis. 
Research in Experimental Medicine, 229(1978), 223–229. 
Winick, M., & Noble, A. (1966). Cellular response in rats during malnutrition at various 
ages. The Journal of Nutrition, 89(3), 300–306.  
Wong, P. M., Lees, A. N., Louw, J., Lee, F. Y., French, N., Gain, K., & Chambers, D. C. 
(2008). Emphysema in young adult survivors of moderate-to-severe 
bronchopulmonary dysplasia. European Respiratory Journal, 32(2), 321–328.  
Yu, L. M. Y., Lu, J. J., Chan, Y. W., Ng, A., Zhang, L., Hoorfar, M., & Neumann, A. W. 
(2004). Constrained sessile drop as a new configuration to measure low surface 
tension in lung surfactant systems. Journal of Applied Physiology, 97(2), 704–715.  
Zellweger, R., Wichmann, M. W., Ayala, A., Stein, S., DeMaso, C. M., & Chaudry, I. H. 
(1997). Females in proestrus state maintain splenic immune functions and tolerate 
sepsis better than males. Critical Care Medicine, 25(1), 106–110.   
Zuo, Y. Y., Veldhuizen, R. A. W., Neumann, A. W., Petersen, N. O., & Possmayer, F. 
(2008). Current perspectives in pulmonary surfactant - Inhibition, enhancement and 
evaluation. Biochimica et Biophysica Acta - Biomembranes, 1778(10), 1947–1977. 
 
 
 
 
` 
 32 
Chapter 2- Impacts of Fetal Growth Restriction on the Surfactant 
System and Lung Function during Early Postnatal Life 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
` 
 33 
2.1. Introduction 
During pregnancy, maternal nutrient restriction and/or placental malfunction can result in 
fetal growth restriction (FGR), where infants have failed to achieve their growth potential 
in the uterus (Barker et al., 1991; Hoo et al., 2004; Rueda-Clausen, Morton, & Davidge, 
2009). FGR is observed in ~8% of newborns in Canada (Canadian Institute for Health 
Information, 2009). FGR has a variety of health consequences later in life, in a sex-
dependent manner. Focusing on the lung, FGR is associated with constrained early 
postnatal pulmonary development and complications such as decreased lung angiogenesis 
and alveolarization and chronic pulmonary inflammation (Bose et al., 2009; Carey et al., 
2007; Chen et al., 2004; de Onis et al., 1998; Lin & Lechner, 1991; Rozance et al., 2011; 
Winick & Noble, 1966). These changes can lead to persisting impairments that increase 
the risk of respiratory morbidities later in life (Lipsett et al., 2006). Therefore, further 
understanding the pulmonary consequences of FGR is essential to, ultimately anticipate 
and efficiently interfere with its associated clinical risks.  
There is evidence that the developmental changes associated with FGR can affect the lung 
function in early life. It has been shown that FGR, induced by a 50% maternal calorie 
restriction, resulted in lower lung compliance in female mice offspring (Albion, 2011). In 
another study, in the same animal model, it was shown that FGR resulted in changes in 
lung extracellular matrix composition in neonates which later in life caused a reduction in 
lung compliance (Rehan et al., 2012). Also, other studies suggested that FGR caused 
decreases in specific surfactant phospholipids or proteins (Braems et al., 2000;Chen et al., 
2004; Gortner et al., 2005; Joss-Moore et al., 2011; Rozance et al., 2011; Sutherland et al., 
2012) that potentially can impair surfactant biophysical properties and, ultimately, lung 
compliance.  
Based on the above information, previous studies have provided preliminary indications 
that in early life FGR affects lung function and the surfactant system. However, a 
comprehensive analysis is still lacking. It remains unknown whether the impairments 
observed in lung compliance could be the result of potential alterations in surfactant 
metabolism and/or surfactant biophysical function. However, the studies that focused on 
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lung function (Albion, in 2011; Rehan et al., 2012) did not assess whether potential changes 
in the surfactant system were an underlying mechanism responsible for the impairments of 
lung compliance in FGR offspring. Furthermore, the studies that investigated the FGR 
effects on the pulmonary surfactant did not address whether the identified changes in 
specific surfactant components contributed to inefficient lung mechanics. Ultimately, to 
our knowledge, whether FGR has impacts on the total surfactant pool sizes that results in 
alterations in its biophysical properties and the development of lung disease has remained 
unexamined.  
In this study, we hypothesized that FGR induced by maternal protein restriction contributes 
to the alterations of lung mechanics and of the surfactant system in a sex-dependent manner 
during the neonatal period. To test this hypothesis, we utilized an animal model of FGR 
induced by a low maternal protein diet. At different days following birth, lung mechanics 
and in-depth analysis of the pulmonary surfactant system in both male and female offspring 
were performed. 
 2.2. Materials and Methods 
2.2.1. Experimental Design and Ethics Statement 
All procedures were approved by the Animal Use Subcommittee at the University of 
Western Ontario (Protocol Number: 2005-009). A total of 10 female and three male Wistar 
rats at breeding age (250 g) were purchased from Charles River (La Salle, St-Constant, 
Quebec, Canada). Rats were housed in individual cages and allowed to acclimatize for 
three weeks on a 12:12 light: dark cycle with free access to water and standard chow. After 
the acclimatization period, female rats were housed with stud males. The following 
morning, impregnation was confirmed by the presence of sperm in the vaginal smear. Upon 
confirmation of impregnation (gestation d1), pregnant rats were housed individually and 
randomized to one of two dietary conditions: a 20% protein (Control, n=6 litters) or an 8% 
low protein diet (LP, n=4 litter). The LP diet contained equal fat content and was made 
isocaloric by the addition of carbohydrates (Bio-Serv, Frenchtown, NJ). At birth, all the 
litters were culled to 8 and mothers were kept on the same dietary regimes until postnatal 
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d21. Food and water were provided ad libitum. Weights of the male and female offspring 
were recorded at d1, d7, and d21 after birth. 
2.2.2. Analysis of Lung Mechanics 
Rats at postnatal d7 and d21 were euthanized with an intraperitoneal injection (IP) overdose 
of Sodium pentobarbital (110mg/Kg of body weight [BW]). After performing a 
tracheostomy and exposing the lungs, animals were connected to the FlexiVent (SCIREQ, 
Montreal, Quebec, Canada) for ex vivo measurements of lung function. Following 
connecting to the FlexiVent, rats were immediately exposed to 1min ex vivo mechanical 
ventilation (Vt=10ml/kg, RR=120breath/min, PEEP=0cm). Prior to measurements, to 
standardize volume history, deep inflation was applied to the lungs from PEEP value to 
about a pressure of 30cmH2O. Following deep inflation, we performed two different 
perturbations: a snapshot perturbation and a prime-8 (Ask et al., 2008; Robichaud et al., 
2015). These software-controlled perturbations were performed with 10 seconds intervals 
of ex vivo ventilation. The snapshot perturbation was applied to measure compliance and 
resistance of the whole respiratory system. Prime-8 perturbation outcomes were values for 
proximal airway resistance, and tissue elastance.  
2.2.3. Bronchoalveolar Lavage collection, Surfactant Isolation and Analysis  
Following lung function measurements, whole-lung bronchoalveolar lavages (BAL) were 
collected through flushing the lungs with saline. For d7 and d21, lungs were lavaged with 
4 or 5 aliquots of saline, respectively. For d1 offspring, BAL fluids were collected directly 
after euthanasia (Sodium pentobarbital IP overdose [110mg/Kg BW]) and tracheostomy; 
lungs were lavaged with four aliquots of saline. The total volumes of administered and 
recovered saline were recorded. The lavage samples were centrifuged at 150g for 10min at 
4°C to remove all cellular debris from the lavage resulting in a supernatant containing the 
total surfactant (TS). A volume of TS (~300ul) was stored at -20°C and the remaining 
volume was centrifuged at 40,000g for 15min to separate the surface-active large aggregate 
(LA) surfactant subfraction from the supernatant, which contained the inactive small 
aggregates (SA) surfactant subfraction. The LA pellets were then re-suspended in saline, 
and both LA and SA subfraction were stored at -20°C for further analysis. The phospholipid 
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contents of TS, LA, and SA lipid extracts were chloroform-methanol extracted and 
measured using a phosphorous assay as previously described (Bligh & Dyer, 1959; Duck-
Chong, 1979). Due to significant differences in body weights between control and LP 
groups, values for surfactant phospholipid levels were calculated as the amount of 
phospholipid corrected for body weight (mg of the total phospholipid in BAL/gBW). 
Ultimately, using these corrected values, we calculated the percent LA (LA/(LA+SA)) in 
each experimental group.  
2.2.4. Bronchoalveolar Protein Measurements  
Protein concentration in BAL for d21 samples was measured using a Micro BCA protein 
assay kit (Pierce, Rockford, Ill., USA) according to manufacturer’s instructions. 
2.2.5. Surfactant Biophysical Analysis 
Aliquots of LA were centrifuged at 21,000g for 15 minutes at 4°C, and the resulting pellets 
were re-suspended at a concentration of 2mg/ml phospholipid in a buffer containing 
140mM NaCl, 2.5mM HEPES, and 1.5mM CaCl2, pH=7.4. Samples were incubated at 
37°C for about 1hr prior to assessing their surface tension reducing ability using a 
constrained sessile drop surfactometer (CDS) as previously described (Milos et al., 2017; 
Valle, Wu, & Zuo, 2015). Briefly, a droplet of LA sample (~10µl) was dispensed onto the 
CDS drop holder. The droplet was allowed to equilibrate for 2 minutes to allow for 
surfactant adsorption. Following adsorption, the droplet was exposed to 20 dynamic 
compression-expansion cycles on the CDS using a computer-controlled stepper motor 
(LTA-HS actuator, Newport Corporation, Irvine, CA, USA). Compression-expansion 
cycles were applied at a frequency of 20 cycles per minute and intended compression to 
~70-75% of the original area of the droplet. During the dynamic compression-expansion 
cycles, images of the droplet were taken at a rate of 10 frames per second and the recorded 
images were analyzed with Axisymmetric Drop Shape Analysis software to assess the 
sample surface tension and the surface area of each picture.  
To better understand the information obtained by biophysical analysis of compression-
expansion outcomes, an example of an isotherm (surface tension versus surface area) with 
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different surfactant biophysical parameters is shown in Figure. 2.1 The figure displays the 
first compression-expansion cycle of a surfactant LA sample, at 2mg/mL phospholipid. 
Before compression, the sample is at its equilibrium surface tension. Over the compression, 
reducing in surface area directly causes lowering of the surface tension. While during 
expansion, increases in surface area result in increasing surface tension. 
 
Figure 2. 1. A representative surface tension versus relative surface area (fractional area) 
isotherm at the first dynamic compression-expansion cycle assessed on the constrained 
sessile drop surfactometer (CDS). Samples were compressed (-o-) and expanded (-●-). 
Isotherms give information on surface tension following adsorption (equilibrium surface 
tension at cycle 1), minimum surface tension, maximum surface tension, and maximum 
compression needed to achieve minimum surface tension. 
2.2.6. Statistical Analysis  
All data are expressed as mean ± standard error of the mean (SEM). All statistical analyses 
were performed using the GraphPad Prism statistical software (GraphPad Software, Inc., 
La Jolla, CA., USA). Statistical comparisons for weights between control and LP neonatal 
offspring were performed using an unpaired, two-way student’s t-test. Data analysis for 
lung mechanics parameters and surfactant phospholipid contents, as well as statistical 
comparisons for large aggregate surfactant function were performed using a two-way 
repeated measures ANOVA with Bonferroni post hoc test. Technical replicates of 
surfactant function assessed on CDS were averaged as an individual data point. Probability 
(p) values of less than 0.05 were considered statistically significant. 
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2.3. Results 
2.3.1. Effects of LP on Body Weight 
Body weights for both male and female LP offspring were significantly lower compared to 
control males and females at d1 and d21. There was a non-significant trend in body weights 
of LP male and female offspring compared to controls at d7. Further analysis showed no 
significant differences in body weights between sexes (males vs. females) in the same 
dietary groups at each experimental day (Table 2.1).  
Table 2. 1. Numbers and body weights of LP and control offspring at d1, d7, and d21 
10 
Litters d1 d7 d21 
n=148 
 Control LP Control LP Control LP 
Males 
7.0 ± 0.2 
n=16 
6.3* ± 0.3 
n=13 
21.2 ± 1.2 
n=10 
17.2 ± 1.5  
n=6 
73.5 ± 2.5 
n=10 
50.1* ± 4.0 
n=10 
Females 
6.6 ± 0.2 
n=26 
5.8* ± 0.1 
n=19 
18.5 ± 1.6   
n=8 
15.7 ± 0.7 
n=11 
71.4 ± 3.0 
n=10 
45.9* ± 4.7   
n=4 
Body weights of d1 and d21 LP males and females were significantly lower compared to 
controls (*= p < 0.05 vs. control). There was a non-significant trend in body weights of LP 
offspring at d7 compared to controls (p>0.05). Data are expressed as means ± SEM 
2.3.2. Lung Functional Analysis 
Lung functional assessments in males and females at d7 and d21 are shown in Figure. 2.1. 
Lung functional assessments include: i) whole lung compliance (measure of lung 
expandability), ii) tissue elastance (measure of the lung’s parenchymal stiffness), iii) whole 
respiratory airway resistance (proximal and peripheral airway resistance combined), and 
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iv) proximal airway resistance. 
 2.3.2.1. Lung Function Analysis at d7  
Data analysis at d7 showed that LP diet had no effects on different parameters of lung 
function in males or females (p>0.05) (Fig. 2.2).  Also, further analysis between males and 
females at d7 displayed no changes in parameters of lung function between sexes with the 
same diet: there were no significant changes between control males compared to control 
females (p>0.05) or between LP males compared to LP females (p>0.05). 
2.3.2.2. Lung Function Analysis at d21 
Lung compliance and Tissue Elastance 
Data analysis showed that LP resulted in alterations of lung compliance and tissue elastance 
in d21 females compared to controls (p<0.01) (Fig. 2.2. A). However, LP did not result in 
a significant difference in lung compliance in d21 males compared to controls (p>0.05). 
Furthermore, tissue elastance showed higher elasticity only in LP d21 females compared 
to control females (p<0.01) (Fig. 2.2.B). 
Whole Respiratory and Proximal Airway Resistance 
Increase in whole respiratory airway resistance (Fig. 2.2 .C) was observed in response to 
LP diet in both d21 males (p<0.001) and females (p<0.05) compared to their respective 
control groups. However, proximal airway resistance (Fig. 2.2. D) displayed increases in 
LP males only compared to control males (p<0.001).  
2.3.2.3. Lung Function Analysis: d21 versus d7  
Further data analysis demonstrated some significant changes from d7 to d21: i) Lung 
compliance of d21 males and females were significantly higher compared to the same sex 
and diet groups at 7 (p<0.001), ii) in control groups, from d7 to d21, there were significant 
decreases for whole respiratory and proximal airway resistance (p<0.01 and p<0.001), and 
similar significant differences were observed in LP groups (p<0.01 and p<0.001).   
` 
 40 
 
  
 
 
Males Females
0.00
0.02
0.04
0.06
0.08
d7
n=8 n=5
n=3 n=8
m
L/
cm
H
2O
Males Females
0.00
0.02
0.04
0.06
0.08 Control
LPn=8 n=9
n=8
n=4
d21
**
m
L/
cm
H
2O
A.Whole Lung Compliance
Male Female 
0
20
40
60
80
Control
LP
n=8
n=4
n=8 n=9
d21
**
cm
H
2O
/m
L
Male Female 
0
20
40
60
80 n=6 n=4 n=3 n=7
d7
cm
H
2O
/m
L
B.Tissue Elastance 
Males Females
0
2
4
6
8
10
d7
n=8
n=5
n=3 n=8
cm
H
2O
.s
/m
L
Males Females
0
2
4
6
8
10 Control
LP
n=8 n=9 n=9 n=4
d21
****c
m
H
2O
.s
/m
L
 C.Whole Respiratory Airway Resistance
` 
 41 
  
Figure 2. 2.  Analysis of respiratory mechanics in Control and LP males and females at 
postnatal d7 and d21. (A) Whole lung compliance, (B) tissue elastance, (C) whole 
respiratory airways resistance, and (D) proximal airway resistance. Data are expressed as 
means ± SEM, *= p < 0.05 and **= p < 0.01vs. control. 
 
2.3.3. Bronchoalveolar Surfactant Analysis 
The total volumes of saline used to lavage the lungs (infused volumes) and the total 
volumes of collected BAL are displayed in Table 2.2. For d1 and d7, during lavaging, the 
same volumes of saline could be infused into the lung lumen of LP and control offspring. 
However, at d21, there were significant differences for the volumes of infused saline 
(p<0.05, p<0.01) between LP males and females compared to their respective control 
groups. Similar results were observed for collected volumes of BAL (p<0.01, p<0.001). 
The results for BAL phospholipid measurements for TS and the surfactant sub-fractions 
(LA and SA) are shown in Figure. 2.3. Values for surfactant phospholipid levels have been 
presented as the amount of phospholipid corrected for the body weight (µg/g of body 
weight). 
2.3.3.1. Large and Small Aggregate Phospholipid Levels  
Overall, there were no significant differences for LA or SA phospholipid levels between 
LP offspring compared to the control groups at d1, d7, or d21 (p>0.05). Results showed 
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that in control d7 and d 21 offspring of both sexes surfactant levels were lower compared 
to d1 offspring of the same sexes (p<0.05). However, there were no further differences in 
surfactant levels between d7 and d21 offspring (p>0.05). Similar findings were observed 
in LP groups at d7 and d21 compared to d1 offspring. 
2.3.3.2. Large Aggregate Surfactant Percent   
Further analysis demonstrated that percent LA (LA/(LA+SA)) (Figure. 2.4) did not change 
in response to LP diet at different ages versus control groups (p>0.05). In addition, although 
from d1 to d7 there were no changes in percent LA (p>0.05), however, d21 offspring had 
significant higher LA percent levels in both sexes compared to d7 and d1 (p<0.05). Also, 
similar results were observed for LP groups.  
2.3.3.3. Surfactant Analysis Between Sexes 
Finally, comparisons between control males and females displayed no differences in LA 
and SA phospholipid levels or LA at different days (p>0.05) with similar results were 
observed in LP males and females (p>0.05).  
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Table 2. 2. Total volumes of saline used to lavage the lungs and volumes of collected 
BAL. 
  Control Diet LP Diet 
 Volume (ml) Males Females Males Females 
d1 
Infused Saline 1.6 ± 0.1  1.6 ± 0.1  1.5 ± 0.2 1.4 ± 0.1 
Collected BAL 1.4 ± 0.1 1.5 ± 0.1  1.3 ± 0.1 1.2 ± 0.1 
  
d7 
Infused Saline 3.3 ± 0.3 3.2 ± 0.3 3.1± 0.2 2.8 ± 0.2 
Collected BAL 3.0 ± 0.4 2.6 ± 0.4 2.5 ± 0.3 2.5 ± 0.2 
  
d21 
Infused Saline 15.8 ± 1.0 14.7 ± 1.5 9.1 ± 1.1## 7.2 ± 0.2# 
Collected BAL 14.2 ± 1.0 12.5 ± 1.0 8.1 ± 1.2*** 6.4 ± 0.4** 
Except for LP d21 males and females, there was no significant difference between the total 
volumes of saline infused in and total BAL collected (p>0.05) between other groups.  
**=p<0.01 vs d21 control females, ***=p<0.001 vs d21 control males, #=p<0.01 vs d21 
control females, ##=p<0.001 vs d21 control males.  
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Figure 2. 3. Surfactant pool sizes of BAL fluids recovered from control and LP rat 
offspring. Surfactant pool sizes of (A) TS, (B) LA, and (C) SA measured by phosphorous 
assay. Data are expressed as amount of phospholipids/g body weight. Values are expressed 
as mean ± SEM, within each surfactant subfraction p>0.05 vs controls.  
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Figure 2. 4. Percent large aggregates measure in BAL at d1, 7 and 21 in LP and Control 
males and females. Data are expressed as mean ± SEM, p>0.05 vs controls.  
 
2.3.4. Surfactant Biophysical Activity 
Biophysical properties of isolated LA were assessed on CDS. Results for biophysical 
measurements have been presented in Figure 2.5, and Table 2.3. In this study, the minimum 
surface tensions that were achieved during compressions of LA samples were used as the 
primary indicator for biophysical assessment of surfactant. Surface tension upon 
adsorption (equilibrium surface tension) was also analyzed. The other measured 
biophysical parameters were maximum surface tension during expansion and compression 
required to reach minimum surface tension during each cycle. Figure. 2.5. shows two 
representative compression-expansion isotherms (at cycle 10) for d21 LP and control males 
and females. These isotherms demonstrated a reduction in surface tension during 
compression to ~7-10mN/m (Figure. 2.5. A) for LP and control males and to ~6-7mN/m 
(Figure. 2.5. B) for LP and control females. Isotherms show that the compressions required 
to achieve minimum surface tension for LP and control males and females were ~70-74% 
of the original area of the LA droplets. 
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Figure 2. 5. Representative surface tension (mN/m) versus relative surface area (fraction 
of the initial area) isotherms at dynamic compression-expansion cycle 10 of LA isolated 
from rats with control and LP diets. Compressions are connected with back (-) and 
expansions with grey ( ) lines.  
Minimum surface tensions achieved by LA samples at different cycles (cycle 1 to 20) for 
control and LP offspring at d1, d7, and d21 have been shown in Figure 2.6 A-C. Data 
analysis revealed that at each postnatal day there were no significant differences in 
minimum surface tension at any cycle for LP males and females compared to respective 
control groups (p>0.05). Furthermore, at each day no difference was observed in surface 
tension between control males and females of the same diet (p>0.05). The same statistical 
outcomes were observed for the comparison between LP males and females at different 
ages (p>0.05).  
Results for equilibrium surface tension upon adsorption and other surfactant biophysical 
parameters at cycle 10 have been shown in Table. 2.3. Statistical analysis displayed no 
significant difference in equilibrium surface tension following 60-120 seconds of 
adsorption on CDS pedestal in isolated LA surfactant from LP offspring compared to 
controls for d1, d7, and d21 (p>0.05). Furthermore, there was no significant difference 
observed in maximum surface tension achieved between LP and control groups at different 
days. Lastly, a comparison between LP and control groups showed no statistical differences 
for maximum compression at cycle 10 (p>0.05). 
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Figure 2. 6. Minimum surface tension during different cycles. Measurements of minimum 
surface tension (mN/m) during 20 dynamic compression-expansion cycles of LA samples 
isolated from BAL fluids at (A) d1, (B) d7, and (C) d21.Control vs LP diet. Data are 
expressed as mean ± SEM, p>0.05.  
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Table 2. 3. Surfactant equilibrium surface tension upon adsorption, area compression 
ratios and maximum surface tensions at cycle 10 for control and LP rats at d1, d7, and 
d21. 
 
Age 
Male Female 
 Control diet LP diet Control diet LP diet 
Surface Tension 
Following 
d1 25.2 ± 1.3 26.0 ± 0.6 25.2 ± 0.3 26.0 ± 0.6 
Adsorption   d7 24.1 ± 1.0 25.1 ± 2.1 24.8 ± 1.2 24.7 ± 0.5 
(mN/m) d21 23.8 ± 0.4 23.5 ± 0.4 23.7 ± 0.5 23.4 ± 1.1 
       
% of the Original 
Area  
d1 72.0 ± 2.2 74.4 ± 4.1 71.4 ± 2.2 69.2 ± 1.8 
at Min Surface 
Tension 
d7 70.1 ± 1.6 71.8 ± 5.0 74.1 ± 3.3 72.7 ± 2.4 
 (Cycle 10) d21 71.1 ± 0.9 71.5 ± 1.0 70.1 ± 0.6 73.4 ± 1.6 
        
Max Surface 
Tension 
d1 36.8 ± 2.1 38.2 ± 1.1 41.5 ± 1.5 40.9 ± 0.1 
(mN/m)  d7 40.7 ± 0.9 44.4 ± 1.4 36.3 ± 2.2 41.5 ± 1.2 
(Cycle 10) d21 36.4 ± 1.2 36.2 ± 1.1 37.9 ± 1.8 33.7 ± 2.0 
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 2.3.5. BAL Protein Content  
The analysis of BAL protein contents at d21 for males and females is shown in Figure. 
2.7. Overall, there were no significant differences for protein contents in LP offspring 
compared to the control groups. 
 
Figure 2. 7. Total protein content in BAL fluids from d21 males and females control and 
LP groups. Data are expressed as mean ± SEM, p>0.05 vs controls.  
  
2.4. Discussion 
In this study, we hypothesized that FGR induced by maternal protein restriction contributes 
to the alterations of lung mechanics and of the surfactant system in a sex-dependent manner 
during the neonatal period. Results demonstrated altered parameters of lung mechanics at 
d21 in a sex-specific manner. We showed that lung compliance and tissue elastance were 
significantly different in LP female offspring at d21. Furthermore, results for surfactant 
analysis demonstrated that at different postnatal days LP diet has no effect on the surfactant 
pool sizes or biophysical properties. Also, no alterations were observed in surfactant 
reducing surface tension ability. It is concluded that, during the neonatal period, FGR 
causes significant alterations to lung compliance in a sex-specific manner without having 
any impact on the surfactant system.   
An important feature of this study was to analyze the surfactant system and lung function 
in an established clinically relevant animal model of FGR induced by maternal low protein 
diet (LP). Similar to previous studies that utilized LP the animal rat model (Petry, Ozanne, 
& Hales, 2001; Snoeck et al, 1990), we successfully observed lower body weight in LP 
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male and female newborns (d1) compared to control offspring. Furthermore, another 
advantage of this animal model was that compared to, relatively, invasive hypoxia or utero-
placental interventions, LP is accompanied with significantly less reported maternal 
mortality and fetal resorption (Hayashi & Dorko, 1988).  
Maintaining large surfactant pool sizes at birth, relative to the later ages, is nescessary to 
ease the opening of the lungs upon the transition to the air-breathing environment. 
Furthermore, alveolarization process in rats begins and progress during postnatal day 7-
day 21 period (Burri, 1992; Schittny, Mund, & Stampanoni, 2008). Therefore, any changes 
in surfactant contents or lung function at day 1 or between day 7-day 21 would implicate 
in alterations in the lung development and pulmonary alveolarization process. Based on 
this knowledge, surfactant pool sizes and lung function were assessed during day 1 to day 
21 postnatal life. The most interesting observation made in the current study is the 
significant decrease in lung compliance at d21 in LP female, but not male, rat offspring. 
Consistent with this decrease in lung expandability in this experimental group were 
measurements of increased tissue elasticity (stiffness). A similar observation was made 
previously using a maternal calorie restriction mouse model of FGR (Albion, 2011). In that 
study, only reported in a thesis format, lung functional measurements showed that 30-day 
old FGR female mice had lower lung compliance compared to control female mice (with 
no effects on males). Together, these studies provide strong support of the novel finding 
that FGR can lead to altered lung compliance in the neonatal period in a sex-dependent 
manner.  
To further investigate the potential underlying mechanism of decreased lung compliance 
we investigated the pulmonary surfactant system. In general, lung compliance is affected 
by lung structure and the function of the pulmonary surfactant system. On the other hand, 
all the previous studies that investigated the effect of FGR on the pulmonary surfactant 
only measured the levels of specific surfactant phospholipids or proteins in the total 
surfactant (mostly intracellular surfactant) (Chen et al., 2004; Gortner et al., 2005; 
Sutherland et al., 2012). A novelty of my study was, for the first time, I assessed the effects 
of FGR on the surfactant biophysical activity. Furthermore, I separated and measured the 
LA surface active and SA inactive surfactant components in a FGR animal model, which 
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was not in those previous studies. Since the data showed no differences in the amounts of 
surfactant or the biophysical activity, it appears unlikely that surfactant was a contributor 
to decreased lung compliance in 21-day old female mice. Thus, although not investigated 
in the current study, it is possible that structural alterations may be responsible for the 
observed effect on the lung function. Previous studies showed that the most common cause 
of increased tissue stiffness is changes in lung structure by altered expression and 
deposition of lung extracellular matrix (ECM) proteins, most importantly collagen and 
elastin (Lindahl et al., 1997; Weibel, 2011). Also, Rehan et al., in 2012, showed that FGR 
induced by maternal calorie restriction resulted in increased levels of collagen subtypes in 
the lung parenchyma in 21-day old rats (males only examined). Further studies, such as 
parenchymal morphological and ECM compositional assessments, are required to 
specifically address the potential structural changes due to FGR and differences among 
male and female offspring in this process.  
Although the main focus of our study was to study the impact of FGR, it is of interest to 
note that surfactant levels differed among the different age groups in both male and female 
offspring. Surfactant analysis in different age groups showed relatively higher levels of 
total surfactant and LA pool sizes at d1 compared to the later ages. Of note, due to 
differences in body weights between different age groups, the values for surfactant pool 
sizes were corrected for body-weight to allow for age comparisons. In a previous study, a 
large surfactant pool size was observed at birth in healthy male offspring (Runge & 
Patterson, 2007). This study suggested that large surfactant pool sizes at birth is necessary 
to facilitate opening of the lungs upon the transition to the air-breathing environment. Our 
results supported this previous observation and expanded upon it by first, showing that the 
same regulating mechanism to maintain high surfactant pool sizes existed in control female 
animals, and second, the mechanism was conserved even in LP newborn males and 
females. 
Our findings on lung compliance and tissue stiffness in FGR offspring may have clinical 
implications. As mentioned above, ECM macromolecules, most importantly collagen and 
elastin, are responsible for regulating the parenchymal mechanical properties. Also, these 
proteins, especially collagen, have important roles in regulating homeostasis and cellular 
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responses to injury. Previous studies showed that chronic dysregulated parenchymal 
homeostasis co-existing with tissue stiffness may indicate the risk of pulmonary 
complications such as the progress of fibrosis, alveolar collapse and an increased risk of 
chronic lung disease (Lambert et al., 1992; Suki & Bates, 2008; Thibeault et al., 2003). In 
later ages into adulthood, these potential changes can make the pulmonary system more 
susceptable to different respiratory morbidities with severe clinical outcomes. To explore 
these potential outcomes in FGR adults, the next chapter of this thesis examined the effects 
of FGR on the susceptability of adult rats to develop lung injury in response to sepsis (as a 
common insult) in the same LP model.   
It should be mentioned that this study was associated with some limitations. For example, 
in terms of practical limitations it should be noted that i) the FlexiVent that was used to 
assess the lung function was not designed for very small d1 offspring, therefore, we could 
not examine the FGR impacts on the lung function upon the transition to the extra-uterine 
environment, ii) we could not determine whether the reduced lung compliance in LP at d21 
contributed to physiological symptoms, such as altered gas exchange and blood 
oxygenation levels, iii) since surfactant analysis requires lung lavage procedures which 
would invalidate structural analyses, there were not enough pups to perform structural 
assessments in LP neonates in addition to our surfactant analysis; this is considered a 
potential future direction, and iv) finally, due to the diversity of initiating mechanisms 
responsible for inducing FGR and, also, genetics and physiologic variations between 
different animal models and humans, our single animal model does not represent all the 
pulmonary clinical features associated with FGR.   
2.5. Conclusions 
Overall, this study showed that, during early postnatal life, maternal protein restriction-
induced FGR is associated with changes in pulmonary mechanics in the absence of 
surfactant alterations. Furthermore, our findings demonstrated a sex-dependent role for the 
impact of FGR on the development of lung functional impairments. This emphasizes the 
need for further understanding of the underlying mechanisms of pulmonary complications 
associated with FGR during the fetal period and their long-term impacts during adulthood.  
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Chapter 3- Effects of Fetal Growth Restriction on the Pulmonary 
Surfactant System in Response to Sepsis in Adult Rats 
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3.1. Introduction 
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host 
response to a systemic infection (Fein & Calalang-Colucci, 2000). The systemic infection 
and inflammation can have ultimately impacts on different organs with the lungs being one 
of the first organs adversely affected (Shorr et al., 2006). Unfortunately, despite the 
improvements in understanding the pathophysiology associated with sepsis, there are no 
proven specific pharmacotherapies to reverse or even stop sepsis-induced lung injury 
(Anzueto et al., 1996; Luce et al., 1988; Spragg, 2002; Yu & Tomasa, 1993). As such, 
pulmonary complications caused by sepsis contributes to high mortality in critically ill 
patients (Stapleton et al., 2005). Therefore, it is important to identify the factors that 
influence the development of pulmonary alterations due to sepsis.   
There is clinical evidence that patient-specific factors may have impacts on the incidence 
and development of sepsis and sepsis-induced lung injury. There is experimental and 
epidemiological evidence indicating that sex, age, and chronic comorbidities (such as 
diabetes and hypertension) are important factors affecting patient’s risk for developing 
sepsis developing sepsis and sepsis-induced lung injury (Heffernan et al., 2011; Kadioglu 
et al., 2011; Martin et al., 2003; Oberholzer et al., 2000; Zellweger et al., 1997). Therefore, 
a septic insult in different individuals may elicit significantly different systemic and 
pulmonary outcomes (Danai et al., 2006; Martin et al., 2003). There is evidence that fetal 
growth restriction (FGR) represents a risk factor affecting the pulmonary responses to 
sepsis. In general, FGR is associated with adult on-set diseases and complications such as 
diabetes, cardiovascular disorders, and chronic systemic and pulmonary inflammation 
(Barker et al., 1991; Karadag et al., 2009; Murki & Deepak, 2014; Vega et al., 2016; Wong 
et al., 2008). There are underlying shared mechanisms between these diseases and sepsis-
induced severe lung injury, such as inflammation and elevated levels of ER/oxidative stress 
(Lv et al., 2013; Maritz et al., 2004; Vega et al., 2016). The impact of FGR on septic 
responses within the lung have not previously been examined. 
Previous animal studies, mostly performed in young healthy male mice and rats, have 
examined the effects of sepsis on the pulmonary system (Bailey et al.,2002; Huang et al., 
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2005; Luo et al., 2017). These studies showed alterations in the lung surfactant system such 
as decrease in surfactant levels and inhibition of the surfactant function as well as 
pulmonary inflammation. On the other hand, there is strong clinical evidence indicating 
sex-specific differences in the development of sepsis-induced systemic inflammation and 
lung injury (Kadioglu et al., 2011; Martin et al., 2003; Oberholzer et al., 2000); the 
incidence of sepsis and sepsis induced-lung injury is higher in males.  
In this study, it was hypothesized that in adult rats, FGR affects the sepsis impacts on the 
surfactant system in a sex-dependent manner. To test our hypothesis, we used an animal 
rat model of FGR induced by a maternal low protein diet. Sepsis was induced by fecal 
intraperitoneal injection. This study included both male and female offspring allowing the 
assessment of sexual dimorphism on pulmonary surfactant and the development of lung 
injury. 
3.2. Materials and Methods 
3.2.1. Experimental Design and Ethics Statement 
All procedures were approved by the Animal Use Subcommittee at the University of 
Western Ontario (Protocol Number: 2017-003). A total of 15 female and 5 male Wistar 
rats at breeding age (250g) were purchased from Charles River (La Salle, St-Constant, 
Quebec, Canada). Rats were housed in individual cages and allowed to acclimatize for 3 
weeks on a 12:12 light:dark cycle with free access to water and standard chow. After the 
acclimatization period, female rats were housed with stud males. The following morning, 
impregnation was confirmed by the presence of sperm in the vaginal smear. Upon 
confirmation of impregnation, pregnant rats were housed individually and randomized to 
one of two dietary conditions: a 20% protein (Control, n=7 litters) or an 8% low protein 
diet (LP, n=9 litters). The LP diet contained equal fat content and was made isocaloric by 
the addition of carbohydrates (Bio-Serv, Frenchtown, NJ). At birth (d1) offspring weights 
were recorded and the litter size was reduced to ten animals. This ensured a standard litter 
size for all mothers. After birth, mothers were kept on the same dietary regimes until 
postnatal d21. Male and female offspring were weighed and separated at postnatal d21. 
Food and water were provided ad libitum. Since d21, all the offspring were fed with the 
` 
 60 
control protein diet until between d130-d150 when the rats were randomly assigned into 
sham or septic groups. Weights of the offspring were recorded at d1 and d130-150. 
3.2.2. Sepsis Model 
Sepsis was induced by fecal peritonitis (FIP) by giving each rat an intraperitoneal (IP) 
injection of a fecal slurry according to the following procedure: equal amount of fresh rat 
feces was collected from different experimental groups about 12h before the intraperitoneal 
injection. The collected feces were weighed and mixed with saline solution to give fecal 
concentrations of 0.5g/ml. This fecal slurry was homogenized by vortexing the fecal 
solution for 2min. The collected homogenate was pressed through 4-ply gauze to remove 
particulate matter. Following the filtration, the fecal solution was kept overnight, at 4°C. 
The next morning, 15 min prior to the IP injection upon randomization, analgesia was 
provided by a subcutaneous injection of 0.6ml buprenorphine (0.03mg/ml). Once the 
proper depth of anesthesia was achieved each rat was given an IP injection of the fecal 
slurry solution (1.0ml/100g of body weight [BW]) using a syringe and 21G needle. Sham 
rats were received an injection of sterile saline (1.0ml/100gBW).  
3.2.3. Monitoring of Rats 
We used a standard murine sepsis score (MSS) (Shrum et al., 2014) to monitor and evaluate 
the health of the animals for 6h; 15 min before and after the IP injection, and every 30min 
thereafter. To assess the health of the animals, we used the variables that have been 
described previously (Shrum et al., 2014 and Langford et la., 2010). These variables 
included respiratory quality (i.e. labored breathing or gasping), appearance (i.e. degree of 
piloerection or changes in the eye color), responding to auditory stimuli (i.e. fast or slow), 
and spontaneous activity (i.e. continuous/lack of investigating movements) of the animal. 
Each of these variables was given a score between 0 to 4. In addition, respiratory rate was 
measured at each observation. Rats were euthanized if the total MSS at any given time 
point was greater than 9, or if any of the individual scores increased by more than 3. 
Following completion of 6h monitoring, animals were euthanized with an overdose of IP 
injection of sodium pentobarbital (110mg/KgBW). 
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3.2.4. Blood Collection and Bacterial Culture 
 Immediately after euthanasia, blood samples were taken from abdominal aorta for 
evaluation of systemic infection and inflammatory responses. Colombia blood agar plates 
(BD Bioscience, Mississauga, ON) inoculated with 0.1ml blood samples were incubated 
overnight in an aerobic chamber at 37°C.  The next morning, the plates were checked to 
determine the number of bacterial colony-forming units. The remaining volume of blood 
samples were centrifuged to collect the serum, which was stored at -80°C for cytokine 
analysis.  
3.2.5. Bronchoalveolar Lavage collection, Surfactant Isolation 
Whole-lung bronchoalveolar lavage (BAL) were performed after collecting blood by 
flushing the lungs with saline (~5 x 11ml aliquots of saline). The total volumes of 
administered and recovered saline were recorded. Total volume of BAL was centrifuged 
at 150g for 10min at 4°C to separate all the cellular components. A volume of the 
supernatant (~1.5ml), which contained the total surfactant (TS), was stored at -80˚C for 
cytokine analysis. Also, a 1ml aliquot of TS was stored at -20°C to measure the total 
surfactant content. The remaining volume was centrifuged at 40,000g for 15min to separate 
surfactant large aggregate (LA) subfraction from the supernatant which contained the small 
aggregates (SA) surfactant subfraction. The LA pellets were then re-suspended in 1.0ml 
saline and both LA and SA subfraction were stored at -20°C for further analysis. 
3.2.6. Lavage Cell Analysis  
The isolated BAL cellular component was re-suspended in PlasmaLyte (Baxter Healthcare, 
Dearfeld, IL) (1000 µl to 2000µl depending on cell density). A 25µl aliquot of cell 
suspension was diluted in an equal volume of 0.4% trypan blue to assess viability through 
trypan blue exclusion, and subsequently utilized to determine total cell counts with a 
Bright-Line hemocytometer (Hausser Scientifc, Horsham, PA) and a light microscope (at 
10x magnification). For cell differential, aliquots of cell suspension were spun down on 
cytospin slides at 1000 rpm using a Shandon Cytospin 4 (Termo Scientifc, Cheshire, UK) 
for 6 minutes at room temperature and stained with Hemacolor® (Harleco, EMD 
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Chemicals Inc., Gibbstown, NJ, USA). The stained slides were utilized to perform 
differential cell counts using light microscopy (at 10x magnification). Leukocytes from 
five different fields of view were counted and averaged, and the percentage of each 
inflammatory cell type was calculated. The total number of alveolar macrophages (AM) 
and other proinflammatory cell types in BAL were then obtained by multiplying their 
percent by the total cell number previously determined. Ultimately, concentrations of total 
leukocytes, macrophages, and other proinflammatory cells in BAL were measured.  
3.2.7. Bronchoalveolar Surfactant Measurements  
The phospholipid contents of TS, LA, and SA lipid extracts were chloroform-methanol 
extracted and measured using a phosphorous assay as previously described (Bligh & Dyer, 
1959; Duck-Chong, 1979). Due to significant differences of body weights between 
different experimental groups, values for BAL surfactant phospholipid levels were 
reported as the amount of phospholipid corrected for body weight (mg of the total 
phospholipid in BAL/KgBW). Ultimately, we calculated the percent LA (LA/(LA+SA)) in 
in total volumes of BAL fluids from different experimental groups. 
3.2.8. Bronchoalveolar Protein Measurements  
Total alveolar protein levels were measured in total BAL fluids using a Micro BCA protein 
assay kit (Pierce, Rockford, Ill., USA) according to manufacturer’s instructions. Values for 
BAL protein levels have been presented as the protein concentration in BAL.  
3.2.9. Measurement of Inflammatory Mediators in BAL and Serum  
Concentrations of four cytokines (IL-6, G-CSF, TNF-α, and IFN-γ) and two chemokines 
(KC and MCP-1) were measured in BAL fluids using multiplexed immunoassay kits 
according to the manufacturers’ instructions (R&D Systems, Minneapolis, MN). A Bio-
Plex 200 readout system was used (Bio-Rad), which utilizes Luminex® xMAP fluorescent 
bead-based technology (Luminex Corporation, Austin, TX). Cytokine levels (pg/ml) were 
automatically calculated from standard curves using Bio-Plex Manager software (v. 4.1.1, 
Bio-Rad). 
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Cytokines: IL-6= interleukin-6, IFN-γ= type II interferon, TNF-α= tumor necrosis factor 
alpha, and G-CSF= granulocyte colony stimulating factor  
Chemokines: MCP-1= monocyte chemotactic protein-1 and Chemokines: KC= 
keratinocyte chemoattractant 
3.2.10. Lung Collection and Tissue Fixation 
Following euthanasia, three non-lavaged lungs, from each treatment group, were 
immediately isolated en-bloc. Briefly, the diaphragm was cut and a midline incision was 
performed to open the rib cage and expose the lungs. Lungs were fixed immediately with 
4% paraformaldehyde solution in 0.1M phosphate buffer (pH=7.4) at a pressure of 22-25 
cm water column by the airway instillation method (Weibel, Limacher, & Bachofen, 1982). 
After filling the airways, the trachea was clamped and the intact lungs were immersed in 
the same fixation solution for ~24hr. Fixed lungs were rinsed four times (20 minutes each) 
with 0.1M phosphate buffer (pH=7.4) at 4°C. Each lobe was, consistently, sectioned into 
slices at 3mm thickness and the sections were transferred into 70% ethanol (v/v%). Once 
wax embedded, lungs were sectioned into 6um slices and stained with hematoxylin and 
eosin (H&E) stain for histological assessments. On the H&E stained sections, we did 
preliminary observational assessments. 
3.2.11. Statistical Analysis  
All data are expressed as mean ± standard error of the mean (SEM). All statistical analyses 
were performed using the GraphPad Prism statistical software (GraphPad Software, Inc., 
La Jolla, CA., USA). Statistical comparisons for weights were performed using an 
unpaired, two-way student’s t-test. Data analysis for total MSS, respiratory rate, surfactant 
phospholipid contents, and cytokine measurements were performed using a two-way 
ANOVA followed by a one- way ANOVA with a Tukey’s post hoc test. Probability (p) 
values of less than 0.05 were considered statistically significant. 
3.3. Results  
3.3.1. Effects of LP on Body Weight 
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Data analysis between control and LP groups showed that at d1, body weights for both LP 
male and female offspring were significantly lower compared to control males (p<0.01) 
and females (p<0.05) (Table 3.1. A).  
At d130-d150, body weights for LP males were still significantly lower as compared to the 
control males (p<0.01) while LP did not have a similar effect on female body weights 
(p>0.05) (Table 3.1. B). 
Comparing body weights between sexes showed that were no significant differences 
between male and female body weights at d1 (p>0.05) (Table 3.1. A). However, at d130-
d150, within both diets, females’ body weights were significantly lower compared to 
males’ (p<0.001).  
Table 3. 1. Body weights of (A) newborns and (B) adult rats 
A.  d1 (16 Litters, N=43) Control LP 
Males 7.0 ± 0.3, n=8 6.0**± 0.2, n=8 
Females 6.5 ± 0.2, n=14 5.7* ± 0.2, n=13 
   
B. d130-150 (16 Litters, N=102) Control LP 
Males 660.6 ± 12.3, n=27 591.1*** ± 11.2, n=29 
Females 379.1# ± 7.2, n=23 360.7$ ± 7.5, n=23 
Data expressed as mean ±SE. (A) At d1, LP resulted in lower body weight in both males 
and females (*=p<0.05 vs. control females, **=p<0.01 vs. control males), n=8-14/group. 
However, (B) in adults, LP resulted in lower body weight only in males with no effect on 
females (***=p<0.001 vs. control males). Also, for both diets, adult females’ body weights 
were significantly lower in compared to males’ (#=p<0.001 vs. control males and 
$=p<0.001 vs. LP males), n=23-29/group. 
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3.3.2. Murine Septic Score (MSS) before Euthanasia  
In septic groups, during the experiments, there were 5 animals that were euthanized due to 
reaching a total MSS score greater than 9. All the euthanized animals were septic and were 
from both sexes and diets. There were 1 control male, 2 LP male, 1 control female, and 1 
LP female septic animals that were euthanized before 6hr with a total MSS score>9.  
Before the IP injections, MSS was zero for all the experimental groups. At the end of the 
experiments, before the euthanasia, comparing septic animals to shams revealed that 
regardless of diet and sex, the total MSS in all septic rats were significantly higher 
compared to shams (p<0.001) (Table 3.2). Also, results showed that septic LP offspring 
had higher total MSS than septic controls. Furthermore, data analysis showed no significant 
differences in septic LP males and females and similar results were observed between 
septic control males and females.   
Table 3. 2. MSS scores at t=6h after the IP injection (before the euthanasia). 
Total MSS  
                 Control  LP 
Sham Septic Sham Septic 
Males 1.5 ± 0.3 5.3 ± 0.2*** 0.9 ± 0.2 6.3 ± 0.4*** # 
Females 0.9 ± 0.2 5.2 ± 0.4***   1.2 ± 0.4 6.3 ± 0.4*** # 
Data presented as mean ± SEM. Total MSS was significantly higher in all septic groups 
compared to shams in both diets. Also, further analysis demonstrated higher MSS score for 
septic LP males and females compared to septic controls (***=p<0.001 vs. LP Sham; 
#=p<0.05 vs Control septics). In addition, no differences were observed between septic LP 
males and females. n=10-14/group.  
3.3.3. Respiratory Rate and Respiratory Score 
At the beginning of the experiment, before IP injections, there were no differences for 
respiratory rate (RR) between different experimental groups (data is not shown; p>0.05) 
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regardless of diet and sex. Also, results showed no significant changes in RR among 
different sham groups after 6hr (before euthanasia) (Figure 3.1). However, at the end of the 
treatments, data analysis displayed decreases in RR for all the septic groups compared to 
sham groups (p<0.01). Regardless of sex and maternal diet, at the end of the experiment, 
there were no differences between different sham groups (p>0.05) and similar results were 
observed between septic groups. 
Before the IP injections, respiratory score was zero for all the experimental groups. At the 
end of the experiments, before the euthanasia, comparing septic animals to shams revealed 
that regardless of diet and sex, the respiratory scores in all septic rats were significantly 
higher compared to sham groups (p<0.001) (Table 3.3). Results showed that septic LP 
offspring had higher respiratory scores than septic controls in both males and females 
(p<0.05) (Table 3.3). Furthermore, data analysis showed no significant differences between 
septic control males and females and similar results were observed between septic LP 
males and females (p>0.05).   
 
Figure 3. 1. Respiratory rates (RR) before euthanasia. RR of all septic groups were 
significantly lower than RR of sham offspring 6h after the injection of saline or fecal slurry 
(p<0.01). There were no differences in RR between septic males and females in both diets. 
Data presented as Mean ± SE, **=p< 0.01vs. Shams. n=10-14/group. 
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Table 3. 3. Respiratory score. at t=6h after the IP injection (before the euthanasia). 
Respiratory 
Score 
                 Control  LP 
Sham Septic Sham Septic 
Males 0 0.8 ± 0.1*** 0.2 ± 0.2 1.7 ± 0.2*** # 
Females 0 1.3 ± 0.2***   0 1.8 ± 0.3*** # 
Data presented as mean ± SEM. Respiratory score was significantly higher in all septic 
groups compared to sham in both diets. Also, further analysis demonstrated higher 
respiratory score for septic LP males and females compared to septic controls 
(***=p<0.001 vs. LP Sham; #=p<0.05 vs Control septics). In addition, no differences were 
observed between septic LP males and females. n=10-14/group.  
3.3.4. Blood Culture  
Incubated blood cultures consistently showed bacterial growth in aortic blood samples of 
septic animals (as seen in clinical septic conditions). While blood cultures from sham 
animals showed negative bacterial growth. 
3.3.5. Systemic Inflammatory Mediators 
The effect of LP on the systemic inflammation was assessed at the end of the treatments in 
sham and septic males (Figure 3.2. A-B) and females (Figure 3.3. A-B). The concentrations 
of four cytokines (IL-6, TNF-α, IFN-γ, and G-CSF) and two chemokines (MCP-1 and KC) 
were measured at the end of the treatments in blood serum.  
In sham groups, except for MCP-1 (Figure 3.2. B and 3.3.B), all the inflammatory 
mediators were below the detection range (p>0.05). Statistical analysis for MCP-1 in 
females showed significant differences between septic and sham groups (p<0.05). 
However, there were no differences in MCP-1 concentrations between septic and sham 
groups in both control and LP males (p>0.05).  
Data analysis between septic male control and LP rats displayed no difference (p>0.05) in 
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concentrations of any inflammatory mediators. Similar results were observed between 
septic female control and LP rats (p>0.05). Also, in each dietary group, no significant 
differences in concentrations of different inflammatory mediators were observed between 
septic males compare to septic females (p>0.05). e 
 
Figure 3. 2. Cytokine and chemokine levels measured in blood serum of males. (A) 
Analysis showed that LP did not have a significant effect on (A) cytokine and (B) 
chemokine levels between different septic groups compared to shams. Data presented as 
mean ± SEM, p >0.05. n=4/ sham groups and n=5/septic groups.  
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Figure 3. 3. Cytokine and chemokine levels measured in blood serum of females. (A) 
Analysis showed that LP did not have a significant effect on (A) cytokine and (B) 
chemokine levels between different septic groups compared to shams. Data presented as 
mean ± SEM, p >0.05 vs. Shams. Data presented as mean ± SEM, *=p <0.05 vs. Shams. 
n=4-5/group. 
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3.3.6. BAL Pro-Inflammatory Cell Count and Differentiation 
There were no differences in the total volumes of BAL fluids collected at end of lavaging 
for each group (p>0.05). This allowed us to compare the cell concentrations between 
different groups (Figure 3.4). Results showed no significant changes were observed in 
control septic males and females compared to control shams groups (p>0.05) (Figure 3.4 
A). However, there were decreases observed in concentrations of total cells in BAL of 
septic LP males (p<0.05) and females compared to LP shams (p<0.001). Furthermore, 
data analysis showed no differences in BAL total cells between septic control males and 
females, and similar results were observed between septic LP males and females 
(p>0.05).   
Differential cell counts demonstrated that decreases in concentrations of total cells in BAL 
between LP septic and sham animals were due to alterations in concentration of BAL 
macrophages (Figure 3.4. B) in LP septic rats compared to LP shams. Finally, comparing 
the concentrations of other types of BAL pro-inflammatory cells, including lymphocytes, 
monocytes, and basophiles, regardless of sex and diets, showed no changes between 
different septic and sham animals (p<0.05) (Figure 3.4. C).  
 
 
` 
 71 
 
Figure 3. 4. BAL cell counts and cell differentials. (A) Concentration of total cells in BAL 
in different sham and septic group. Cell differentiation helped to determine the 
concentration of (B) BAL macrophages and (C) other BAL pro-inflammatory cells. Data 
presented as mean ± SEM, *=p<0.05 and ***=p<0.001 vs. Sham LP, n values for different 
experimental groups are the same as presented in Table 3.3 (n= 7-10/group). 
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3.3.7. BAL Surfactant Phospholipid Levels  
The results for BAL phospholipid measurements of TS and surfactant sub-fractions (LA 
and SA) are shown in Figure 3.5. BAL surfactant analysis displayed no changes in LA or 
SA surfactant subfractions between control septic males compared to sham males (p>0.05) 
(Figure 3.5. A). Similar results were observed between control septic females and shams 
(p>0.05) (Figure 3.5. B). 
However, in LP males, there was a reduction in TS phospholipid levels in response to sepsis 
compared to shams (Fig 3.5. A) (p<0.05). Further analysis showed that the difference in 
TS was the result of a reduction in LA phospholipid levels (p<0.05) with no changes in SA 
(p>0.05). In LP females, however, BAL surfactant analysis displayed no changes in LA or 
SA surfactant subfractions in either control or LP females in response to sepsis compared 
to shams (p>0.05). 
In septic and control groups, comparing between sexes showed that LA phospholipid levels 
in LP males was significantly lower compared to LP females (p<0.05). Similar results were 
not observed between control males and females (p>0.05).  
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Figure 3. 5. Surfactant pool sizes of BAL fluids recovered from LP and control male and 
female rats. Data are expressed as mean ± SEM, *=p<0.05 vs. Sham LP (n= 7-10/group). 
 
3.3.8. Percent Large Aggregate in BAL 
Statistical analysis demonstrated that sepsis did not induce significant alterations in LA 
percent whether in LP or control offspring.  
 
Figure 3. 6. Percent large aggregates (LA) measured in BAL fluids recovered from septic 
and sham animals. The data display the proportion of LA/(LA+SA) in total BAL volumes. 
Data have been expressed as mean ± SEM, p>0.05 vs shams (n= 7-10/group). 
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3.3.9. BAL Protein Levels 
The analysis of BAL protein contents for males and females is shown in Fig. 3.7. Overall, 
there were no significant differences for protein contents in response to sepsis whether in 
LP or control groups for both males and females (p>0.05).  
 
Figure 3. 7. Protein levels in BAL fluids. Results showed no significant changes in BAL 
protein levels between different treatments. Data presented as mean ± SEM, p >0.05 vs. 
Shams. n=6-10/group. 
3.3.10.  BAL Inflammatory Mediators 
To further analyze the role of LP in intra-alveolar inflammatory response associated with 
sepsis, the concentrations of four cytokines (IL-6, TNF-α, IFN-γ, and G-CSF) and two 
chemokines (MCP-1 and KC) were measured at the end of the treatments in BAL fluids. 
Levels of these cytokines and chemokines were not detectable in any of the experimental 
groups (data not shown). 
3.3.11. Lung Histology 
Representative images of septic and sham males and females from both maternal diets have 
been shown in Figure 3.8 and Figure 3.9. Preliminary qualitative visual assessments 
illustrated morphological changes in all septic groups compared to shams; it appeared that 
alveolar edema and hemorrhage and thickening of the alveolar cell wall were presented in 
all septic groups.  
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                                  Sham                  Septic 
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Figure 3. 8. Representative images of hematoxylin-eosin stained lung sections from males. 
Images of lung sections from sham and septic control (A, B) and LP (C, D) males, 6h after 
saline or FIP injections. Magnification 10x. Scale bar =100µm shown on the bottom right 
corner of each image. 
A B
C D
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Figure 3. 9. Representative images of hematoxylin-eosin stained lung sections from 
females. Images of lung sections from sham and septic control (A, B) and LP (C, D) 
females, 6h after saline or FIP injections. Scale bar=100µm shown on the bottom right 
corner of each image. 
3.4. Discussion:  
This study addressed the hypothesis that FGR, induced by maternal protein restriction, is 
associated with the development of surfactant alteration and lung injury in response to 
sepsis in a sex-dependent manner during adulthood. The results demonstrated that in 
response to sepsis surfactant pool sizes decreased in adult LP males. The sepsis-induced 
systemic inflammation did not lead to augmented pulmonary inflammation or recruitment 
of pro-inflammatory leukocytes. It is concluded that, in this model of sepsis, FGR resulted 
in alteration of surfactant system in a sex-dependent manner despite the absence of local 
pulmonary inflammation.  
A B
C D
` 
 77 
To test our hypothesis, we utilized a combination of a LP diet-induced model of FGR, with 
a FIP model of sepsis. While several previous studies demonstrated a LP rat model resulted 
in low birth weight in both sexes, as it was shown successfully in this thesis, other studies 
showed LP is a relevant model to study the fetal origins of adult-onset diseases (Petry, 
Ozanne, & Hales, 2001; Snoeck et al, 1990). Studies on adult rats with maternal protein 
restriction demonstrated different clinical FGR adult-onset morbidities associated with this 
model, in a sex-dependent manner, as it has been shown in clinical observations 
(Hennington & Alexander, 2013; McMullen, 2004). Furthermore, results from the current 
study (chapter 2) demonstrated impaired lung function at the end of the lactation period 
(d21) in LP offspring rats. These features allowed us to use the same LP rat model for 
studying FGR pulmonary outcomes during adulthood. Furthermore, given that human 
placental dysfunction can cause protein deficiency in the fetus, LP is a relevant animal 
model of prevalent human placental dysfunction-induced FGR (the common etiology in 
Canada) (Crosby, 1991). Finally, an important feature of this LP animal model was that, 
unlike utero-placental ligation and hypoxia, it was non-invasive and resulted in no 
moralities among the pregnant rats (Hayashi & Dorko, 1988).  
Furthermore, the clinical relevance of this study was based on using an animal model of 
feces-induced peritonitis (FIP). Sepsis was induced in rats by intraperitoneally injecting a 
freshly prepared fecal solution. While this FIP model can lead to the development of 
systemic infection, as we consistently showed by positive bacterial growth, it also mimics 
the pathophysiological alterations associated with human response to sepsis (Wichterman, 
Baue, & Chaudry, 1980). Another feature of this sepsis model was that we did not apply 
general anesthesia; it  has been shown that general anesthesia can suppress the surfactant 
metabolism and lung function (Petrov & Lyubarskii, 1966; Saraswat, 2015). These features 
allowed us to efficiently examine how LP-induced FGR affect the surfactant system in 
response to a clinically relevant condition of sepsis.    
The lack of alveolar inflammatory responses and neutrophil accumulations in septic groups 
was unanticipated. One explanation for the absence of inflammatory mediators in BAL 
fluid was that there was not enough time for the infection to reach the alveolar space and 
trigger an inflammatory response. To assess this mechanism, in future studies, it would be 
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beneficial to extend the treatment for more than 6hr. Also, measuring proinflammatory 
mediator m-RNA and protein levels (i.e. IL-6 and TNF- α) in BAL and lung tissue at 6hr 
can give information about the development and on-set of the inflammation process. 
Furthermore, as previous experimental studies showed that sepsis-induce surfactant 
changes were accompanied by increased alveolar inflammatory responses (Malloy et al., 
1997; Wright et al.,2001), it would be interesting to investigate the underlying mechanism 
responsible for predisposing FGR males to surfactant alterations even in the absence of 
inflammation.  
An interesting novel observation in this study was related to the sex-difference in how FGR 
contributes to surfactant alteration in response to sepsis; in our model, significant decrease 
in alveolar LA surfactant pool sizes was only observed in septic FGR adult males, but not 
females. Also, results demonstrated significant changes in LA levels in FGR septic males 
only. This provided strong support for the novel notion that FGR predisposed adults to the 
development of surfactant deficiency in response to sepsis in a sex-specific manner.  
Whether the sex-dependent surfactant deficiency in septic males can potentially increase 
their susceptibility to develop inhibition of surfactant biophysical function remains to be 
determined. Surfactant inhibition affects the development of severe lung injury. 
Preliminary observational assessments indicated degrees of alveolar edema, hemorrhage 
and thickening of the alveolar cell wall in all septic groups. However, to characterize the 
stage and severity of the injury a comprehensive image analysis needs to be done. As a 
future direction, it can include quantitative assessments such as measuring the septal 
thickening, intra-alveolar infiltration of red blood cells and neutrophils and counting the 
number of intact alveolar type II cells.  
Unanticipated altered LA surfactant content only in male FGR septic animals raised a 
question about the underlying mechanisms. To our knowledge, this study is the first 
demonstration of the sex-specific effect of FGR on the surfactant system in a sepsis model, 
surprisingly, in the absence of a pulmonary inflammatory response. Previous studies on 
pulmonary responses to sepsis, were only done in healthy male animals. From those 
studies, alternated conversion of LA to SA, reduced LA biosynthesis, and clearance of LA 
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by alveolar macrophages have been reported as the mechanisms responsible for alteration 
of surfactant levels (Huang et al., 2005; Wichert et al., 2000). However, whether these 
mechanisms are regulated differently in FGR septic males and females is unknown. 
Therefore, in our study, further studies are required to address the potential mechanism(s) 
responsible for sexual dimorphism in surfactant regulations.  
Since sepsis-induce severe lung injury is a significant clinical problem, it is important to 
speculate on the potential clinical implications of our findings. In the current study, we 
focused on the altertions of the surfactant system as an adverse pulmonary outcome of 
acute lung injury that is applicable to all septic experimental and clinical situations 
(Gregory et al., 1991b; Wiener-kronish, Gropper, & Matthay, 1990). One of the reasons 
for frequent failure of therapies is limited knowledge regrading factors that contribute to 
progression of septic pulmonary outcomes. Therefore, the diagnosis of the disease 
progression, commonly, is possible when it has been already byond the time frame for 
sucesful therapeutic interventions (Walter, Wilson, & Ware, 2014). Our results for 
surfactant levels in septic animals provided support for considering FGR and sexual 
dimorphism as contributing factors affecting the disease progression and severity of the 
outcomes. Thus, based on our experimental animal study, it would be of interest to examine 
if patients that were born with low birthweight have differential outcomes compared to 
people with normal birthweights, and if sexual dimorphism affects the pulmonary sepsis 
outcomes exist in these populations.    
It should be mentioned that this study was associated with some limitations. Practical 
limitations included: i) the animals were not on general anesthesia, therefore, we could not 
examine the potential contributions of FGR to other pathophysiological outcomes, such as 
blood gas and systemic inflammation over the course of sepsis progression, ii) in real 
clinical situations, usually, sepsis-induced surfactant impairments and lung injury develop 
in a few days, however, this study was relatively time-intensive (limited to 6h), and iii) 
finally, due to diversity of initiating mechanisms of sepsis, variety of FGR animal models, 
and variations between animal models and humans, our single experimental model does 
not represent all the clinical features associated with FGR in response to sepsis. 
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3.5. Conclusions 
In conclusion, in response to sepsis FGR predisposed adult rats to the development of 
surfactant alterations even in the absence of pulmonary inflammation. Reductions in 
surfactant levels were observed only in septic FGR males leading to the suggestion that in 
response to sepsis sex is a co-founding variable that impacts the mechanism of surfactant 
alteration in adult rats with FGR. This emphasizes further understanding of the FGR 
impacts on the mechanism of the disease progression in the search for future personalized 
therapeutic interventions. 
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 4.1. Summary 
The first objective of the present study was to examine the effects of FGR, induced by 
maternal protein restriction (LP), on lung mechanics and amounts and function of the 
pulmonary surfactant system during neonatal life (Chapter 2). Also, we tested the effects 
of FGR, induced by maternal protein restriction, on the amounts of pulmonary surfactant 
and development of lung injury in response to a systemic inflammation during adulthood 
(Chapter 3). Furthermore, we assessed whether there is any sexual dimorphism in the 
development of potential FGR-associated pulmonary outcomes both during the neonatal 
period and in adulthood. My hypotheses were I) FGR contributes to alterations of the 
surfactant system and lung mechanics in a sex-dependent manner during the neonatal 
period (Chapter 2) and II) In response to a sepsis-induced systemic inflammation, FGR 
contributes to alteration of the surfactant system in a sex-dependent manner in adults 
(Chapter 3). 
I initially examined the effect of LP on lung function in male and female offspring during 
the lactation period (day 1-day 21). Large broncho-alveolar surfactant levels in newborns 
helps them to immediatelty and maximumally open the lungs upon their transition to the 
air-breathing environment. On ther hands, pulmonary alveolarization process in rat 
neonates begins and progresses between week one and week three after birth. Therefore, 
dysregulated lung development during the neonatal period could alter the surfactant 
production and the lung compliance of the offspring. By investigating different parameters 
of lung mechanics between day 7 and day 21, we observed that at the end of the lactation 
period (day 21), FGR induced decreases in lung compliance of female FGR pups only, 
without affecting FGR males’ lung compliance. Furthermore, an increase in the lung 
stiffness was observed only in FGR females. On the other hand, the study of the effects of 
FGR on the extracellular surfactant system revealed that LP-induced FGR had no impact 
on the alveolar surfactant content or its biophysical function compared to control offspring.  
We speculated that reduction in the lung expandability properties was due to lung tissue 
stiffness, which may have been caused through alterations in parenchymal extracellular 
matrix (ECM) morphology in a sex-dependent manner. ECM proteins such as collagen 
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subtypes and elastin contribute the most to lung parenchymal elasticity (Lindahl et al., 
1997; Ewald R. Weibel, 2011b). Changes in deposition of these proteins have been 
previously observed in a FGR sheep model (induced by umbilico-placental embolization), 
which resulted in thickening of the alveolar cells walls and decreasing alveolarization 
(Joyce et al., 2001; Maritz et al., 2004; Rozance et al., 2011). 
From the beginning, our results raised questions about the potential clinical implications 
of this alteration. Chronic parenchymal stiffness and remodeling during infancy can 
contribute to several pulmonary complications and morbidities such as deregulated 
angiogenesis (Mammoto et al., 2013), immature alveolar formation, developing fibrosis, 
and increased risk for chronic lung disease (Jakkula et al., 2000; Thibeault, Mabry et al., 
2003; Wirtz & Dobbs, 1990). Therefore, although there were no changes in the surfactant 
levels by the end of the lactation period, a persisting lung stiffness potentially may result 
in predisposition of FGR offspring to different pulmonary complications in later ages in a 
sex-dependent manner.  
The second hypothesis was that in response to sepsis, FGR contributes to alteration of the 
surfactant system in a sex-dependent manner in adults. To test this hypothesis, I used a 
combination of an LP model of FGR with a FIP model of sepsis. While it is well understood 
that a maternal LP rat model results in low birth weight offspring in both sexes, some 
compelling studies have shown LP is also a relevant model to study the fetal origins of 
adult-onset diseases (Petry, Ozanne, & Hales, 2001; Snoeck et al., 1990). 
Given that in the first objective it was shown that lung function is affected by FGR during 
infancy, as the second objective, we investigated whether FGR can predispose adult rats to 
the development of surfactant alterations and lung injury in response to sepsis. To pursue 
our objective, we used the same FGR rat model (chapter 2); after d21 all the control and 
LP offspring were fed with a control protein diet until day 130-day 150. Sepsis was induced 
by fecal intraperitoneal injection. This study included both male and female offspring, to 
allow the assessment of sexual dimorphism on pulmonary surfactant and the development 
of lung injury. Our results displayed that intraperitoneal injection of a rat fecal slurry 
successfully induced systemic inflammation in all septic groups. However, surprisingly, 
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there was no intraalveolar inflammation observed in septic animals. Assessment of the 
BAL fluids showed a different impact on the surfactant pool sizes only in adult septic males 
with FGR. These observations have led us to some important conclusions. First, FGR 
predisposed the offspring to develop surfactant impairments in response to sepsis even in 
the absence of pulmonary inflammation. Second, there is a sexual dimorphism associated 
with FGR, which affects the pulmonary surfactant response to sepsis.  
4.2. Future Directions 
Based on our results, which showed an association between FGR and sepsis-induced 
surfactant deficiency, it would be beneficial to expand this study by assessing the effect of 
sepsis-induced surfactant reductions on lung compliance and development of lung injury 
in adult FGR offspring. Also, by assessing lung compliance in adult offspring, it would be 
possible to test whether the sex-dependent changes in lung compliance observed at the end 
of the lactation period persist throughout life. Another potential future direction that could 
complement the current research is the assessment of the biophysical properties of 
surfactant. Clinical and experimental studies have shown significant changes in the 
surfactant levels and biophysical function of the surfactant in sepsis-induced acute lung 
injury/ARDS (Gregory et al., 1991a; Lewis et al., 1994; Wiener-kronish et al., 1990). 
Therefore, to further elucidate the pathophysiological outcome of FGR in a septic lung, 
surfactant biophysical assessment is essential. Furthermore, as in FGR males, surfactant 
depletion occurs before the development of pulmonary inflammation, so the effect of an 
early exogenous surfactant administration can be investigated as a potential therapy to 
interfere with the development of surfactant inhibition and lung injury in FGR offspring. 
Finally, in the current study, the full extent of (potential) FGR-susceptibility to sepsis 
and/or ARDS has not been examined. Our model of sepsis had some lung involvements 
but with no evidence of pulmonary inflammtion. Therefore, in future studies, expanding 
the assessment of FGR effects on the the development of lung injury could involve direct 
lung injuries such as  using the FGR rat model of ventilation iduced lung injury (Milos et 
al., 2017) or intratracheal LPS infection. Such studies would further examine the potential 
harmful effects of FGR associated with lung inflammtion during adulthood.  
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4.3. Concluding Remarks  
Sepsis-induced severe lung injury is a significant clinical problem which can lead to a life-
threatening form of respiratory failure with a mortality rate- higher than the other causes 
of severe lung injury (~60%). Although overall the mortality induced by severe lung injury 
has been decreasing in the last few decades, mostly due to improvements in supportive 
care, there have been no proven effective pharmacological therapies for sepsis-induced 
pulmonary failure nor for preventing its associated adverse outcomes. Most therapeutic 
approaches for sepsis-induce lung injury include exogenous surfactant treatment and anti-
inflammatory therapies. However, due to the complexity of the disease and the likelihood 
of late diagnosis, the therapies have not achieved substantial success. Therefore, 
identifying populations of patients at risk to receive early appropriate therapies could result 
in improvements of the clinical outcome and reducing the mortality rate associated with 
lung failure resulting from sepsis. The findings of the present study have contributed to the 
knowledge of sepsis-associated pulmonary outcomes by i) evaluating FGR as a risk factor 
for developing lung function at early life, ii) identifying FGR as a risk factor for developing 
surfactant deficiency in response to sepsis, and iii) identifying sex differences in response 
to lung function and surfactant deficiency in neonates and adults with FGR, respectively. 
Further experimental and clinical studies are needed to identify the altered underlying 
mechanisms associated with FGR impacts on the lung response to sepsis to ultimately 
provide more effective therapeutic targets and specific treatments to decrease its incidence 
and mortality.   
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